var title_f34_36_35392="Small CMN";
var content_f34_36_35392=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small congenital melanocytic nevus on the palm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The linear streaks of hyperpigmentation reflect the prominent skin markings.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kalman Watsky, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35392=[""].join("\n");
var outline_f34_36_35392=null;
var title_f34_36_35393="Mycosis fungoides patches";
var content_f34_36_35393=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous patches are present on the trunk and proximal extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35393=[""].join("\n");
var outline_f34_36_35393=null;
var title_f34_36_35394="Fingertip testing PI";
var content_f34_36_35394=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F57918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F57918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Fingertip testing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The sides of the fingers have fewer nerve endings than the middle of the fingertips. It might not hurt as much to use the sides of your fingers to test your blood sugar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35394=[""].join("\n");
var outline_f34_36_35394=null;
var title_f34_36_35395="Snare extract billie club";
var content_f34_36_35395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Snare extraction of the Billie club",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Picture demonstrating the Billie club following successful transanal extraction. The colonoscope is also visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Justin A Maykel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35395=[""].join("\n");
var outline_f34_36_35395=null;
var title_f34_36_35396="Potassium iodide and iodine: Drug information";
var content_f34_36_35396=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Potassium iodide and iodine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/9/25748?source=see_link\">",
"    see \"Potassium iodide and iodine: Pediatric drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/6/34916?source=see_link\">",
"    see \"Potassium iodide and iodine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F802367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antithyroid Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F802397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Antiseptic:",
"     </b>",
"     Topical: Apply directly to area(s) requiring antiseptic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      RDA:",
"     </b>",
"     150 mcg (iodine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Preparation for thyroidectomy  (unlabeled use):",
"     </b>",
"     Oral: 5-7 drops (0.25-0.35 mL) 3 times daily; administer for 10 days before surgery; if not euthyroid prior to surgery, consider concurrent beta-blockade (eg, propranolol) in the immediate preoperative period to reduce the risk of thyroid storm (Bahn, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyrotoxic crisis (unlabeled use):",
"     </b>",
"     Oral: 4-8 drops every 6-8 hours; begin administration &ge;1 hour following the initial dose of either propylthiouracil or methimazole (Nayak, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Thyroid gland protection during radiopharmaceutical use (unlabeled use):",
"     </b>",
"     Oral: 20 drops 3 times daily has been recommended (Bexxar&reg; prescribing information, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Initiate 1-48 hours prior to radiopharmaceutical exposure and continue after radiopharmaceutical administration until risk of exposure has diminished (treatment initiation time and duration is dependent on the radiopharmaceutical agent used, consult specific protocol or labeling.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F802396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/9/25748?source=see_link\">",
"      see \"Potassium iodide and iodine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Thyrotoxic crisis (unlabeled use):",
"     </b>",
"     Oral: 4-8 drops 3 times daily; begin therapy preferably 2 hours following the initial dose of propylthiouracil or alternatively, methimazole (Eyal, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F803629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F802404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: Potassium iodide 100 mg/mL and iodine 50 mg/mL (473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical: Potassium iodide 100 mg/mL and iodine 50 mg/mL (8 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F802365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F16350658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Apply topically directly to area(s) requiring antiseptic. Has also been used orally (unlabeled route).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F802370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Topical antiseptic",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F13332997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduce thyroid vascularity prior to thyroidectomy and management of thyrotoxic crisis; block thyroidal uptake of radioactive isotopes of iodine in a radiation emergency or after therapeutic/diagnostic use of radioactive iodine",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F802787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Potassium iodide and iodine (Strong Iodide Solution or Lugol's solution) may be confused with potassium iodide products, including saturated solution of potassium iodide (SSKI&reg;)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F802380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Irregular heart beat",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Confusion, tiredness, fever",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Dermatologic: Skin rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Goiter, salivary gland swelling/tenderness, thyroid adenoma, swelling of neck/throat, myxedema, lymph node swelling, hyper-/hypothyroidism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, gastrointestinal bleeding, metallic taste, nausea, stomach pain, stomach upset, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Numbness, tingling, weakness, joint pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Miscellaneous: Chronic iodine poisoning (with prolonged treatment/high doses); iodism, hypersensitivity reactions (angioedema, cutaneous and mucosal hemorrhage, serum sickness-like symptoms)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F802375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Hypersensitivity to iodine or any component of the formulation; iodine-induced goiter; dermatitis herpetiformis; hypocomplementemic vasculitis; nodular thyroid disease with heart disease",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F802376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypothyroidism: Prolonged use can lead to hypothyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin reactions: Can cause acne flare-ups and/or dermatitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchitis: Use with caution in patients with acute bronchitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac disease: Use with caution in patients with cardiac disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myotonia congenita: Use with caution in patients with myotonia congenita.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid disease: Use with caution in patients with a history of hyperthyroidism; use is contraindicated in nodular thyroid conditions with heart disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tuberculosis: Use with caution in patients with tuberculosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F802385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Potassium Salts may enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: Potassium Salts may enhance the hyperkalemic effect of Angiotensin II Receptor Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Antithyroid Agents may increase the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: May enhance the hyperkalemic effect of Potassium Salts. Management: This combination is contraindicated in patients receiving eplerenone for treatment of hypertension.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Potassium Iodide may enhance the hypothyroid effect of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: Potassium Salts may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Iodide I131: Antithyroid Agents may diminish the therapeutic effect of Sodium Iodide I131.  Management: Discontinue antithyroid therapy 3-4 days prior to sodium iodide I-131 administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Antithyroid Agents may increase the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Antithyroid Agents may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F802371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     D (potassium iodide) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F802372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Iodide crosses the placenta (may cause hypothyroidism and goiter in fetus/newborn). Use for protection against thyroid cancer secondary to radioactive iodine exposure is considered acceptable based upon risk:benefit, keeping in mind the dose and duration. Repeat dosing should be avoided if possible. Refer to Iodine for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F802373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F802374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Skin rash in the nursing infant has been reported with maternal intake of potassium iodide. Refer to Iodine monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F802398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thyroid function tests, signs/symptoms of hyperthyroidism; thyroid function should be monitored in pregnant women, neonates, and young infants if repeat doses are required following radioactive iodine exposure",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F802391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     In hyperthyroidism, iodine temporarily inhibits thyroid hormone synthesis and secretion into the circulation; use also decreases thyroid gland  size and vascularity. Serum T",
"     <sub>",
"      4",
"     </sub>",
"     and T",
"     <sub>",
"      3",
"     </sub>",
"     concentrations can be reduced for several weeks with use but effect will not be maintained.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Following radioactive iodine exposure, potassium iodide blocks uptake of radioiodine by the thyroid, reducing the risk of thyroid cancer.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F802393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Onset of action: Hyperthyroidism: 24-48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Peak effect: 10-15 days after continuous therapy",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/36/35396/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bahn RS (Chair), Burch HB, Cooper DS, et al, &ldquo;Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists,&rdquo;",
"      <i>",
"       Thyroid",
"      </i>",
"      , 2011, 21(6):593-646.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/36/35396/abstract-text/ 21510801/pubmed\" id=\" 21510801\" target=\"_blank\">",
"        21510801",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eyal O and Rose SR, &ldquo;Thyroid Disease,&rdquo; in",
"      <i>",
"       Roger&rsquo;s Textbook of Pediatric Intensive Care",
"      </i>",
"      , 4th ed, David G Nichols, ed, Philadelphia, PA: Lippincott, Williams, &amp; Wilkins, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hassoun A and Oberfield SE, &ldquo;Renal, Endocrine, and Metabolic Disorders,&rdquo; in",
"      <i>",
"       Roger&rsquo;s Textbook of Pediatric Intensive Care",
"      </i>",
"      , 3rd ed, David G Nichols, ed, Philadelphia, PA: Lippincott, Williams, &amp; Wilkins, 2008; p.1658.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nayak B and Burman K, &ldquo;Thyrotoxicosis and Thyroid Storm,&rdquo;",
"      <i>",
"       Endocrinol Metab Clin North Am",
"      </i>",
"      , 2006, 35(4):663-86, vii.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/36/35396/abstract-text/17127140/pubmed\" id=\"17127140\" target=\"_blank\">",
"        17127140",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9455 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-09444732DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35396=[""].join("\n");
var outline_f34_36_35396=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802367\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802397\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802396\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803629\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802404\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802365\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16350658\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802370\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13332997\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802787\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802380\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802375\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802376\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299923\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802385\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802371\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802372\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802373\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802374\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802398\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802391\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802393\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9455\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9455|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?34/6/34916?source=related_link\">",
"      Potassium iodide and iodine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/9/25748?source=related_link\">",
"      Potassium iodide and iodine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35397="Ear barotrauma";
var content_f34_36_35397=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ear barotrauma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     David M Vernick, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35397/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/36/35397/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The middle ear is a gas-filled space. It is separated from the outside world by the tympanic membrane laterally and the Eustachian tube anteromedially. Pressure within the middle ear has to match that of the outside world for the tympanic membrane to vibrate normally and for hearing to sound clear. During normal physiologic function, air in the middle ear is absorbed slowly by the lining mucous membranes and has to be continually replaced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/1\">",
"     1",
"    </a>",
"    ]. This happens normally when one swallows or yawns, opening the eustachian tube for a second and allowing air flow to occur. When the eustachian tube does not function adequately, pressure differences develop between the middle ear and the outside world. These pressure differences can distort the tympanic membrane and lead to discomfort, hearing loss, and injury, otherwise known as barotrauma.",
"   </p>",
"   <p>",
"    This topic will focus on the clinical manifestations, diagnosis, and treatment of barotrauma. Other issues related to eustachian tube dysfunction are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8458?source=see_link\">",
"     \"Eustachian tube dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EUSTACHIAN TUBE FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The eustachian tube extends from the middle ear to the nasopharynx and is made up of two parts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The posterior half leading from the ear is a bony tube lined with mucosa that does not change shape.",
"     </li>",
"     <li>",
"      The anterior half is made of soft tissue that is mucosa lined; it is normally collapsed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The eustachian tube opens momentarily during swallowing or yawning due to actions of the levator veli palati and the tensor veli palati muscles. These muscles elevate and tense the palate and simultaneously open the eustachian tube. This ensures that the eustachian tube is only open when it is protected against reflux from the oral cavity by elevation of the soft palate to close off the nasopharynx. The eustachian tube also needs to be closed most of the time to prevent tympanic membrane motion with respiration (an annoying problem).",
"   </p>",
"   <p>",
"    Dysfunction of the eustachian tube can occur for a variety of reasons. Swelling of the mucosa in the nasopharynx or in the Eustachian tube may occur with infection (eg, upper respiratory infection or acute otitis media) or edema (allergic). This swelling can impede normal eustachian tube function and lead to difficulties in equalizing middle ear pressure, thereby predisposing to barotrauma. Increased tissue mass in the nasopharynx, enlarged adenoids, and nasopharyngeal tumors also may obstruct adequate middle ear ventilation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8458?source=see_link&amp;anchor=H11700640#H11700640\">",
"     \"Eustachian tube dysfunction\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Positive pressure can be generated in the nose and nasopharynx (Valsalva maneuver) to try to overcome the eustachian tube barrier. When the pressure difference is great, air can be forced through the eustachian tube into the middle ear to equalize pressure. Concomitant infection in the nose or nasopharynx may spread to the middle ear with this maneuver.",
"   </p>",
"   <p>",
"    Build up of pressure inside the middle ear is rarely a problem for long (other than with diving); air can usually force its way out of the middle ear via the eustachian tube. Slower equilibration may occur with absorption of the gases by the middle ear mucosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several different causes of ear barotrauma. The most frequently encountered etiology is flying [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Commercial aircraft have pressurized cabins, with the pressure generally equal to that at 7000 to 10,000 feet, not sea level. Outside barometric pressure decreases as the plane ascends. Normally this change is gradual and is equilibrated by swallowing or absorption of air by the middle ear mucosa. The opposite has to occur on descent; air pressure has to increase in the middle ear to balance the increase in atmospheric pressure. When this does not occur, the tympanic membrane is forced medially and stretched. This can lead to bruising of or bleeding into the tympanic membrane, formation of fluid exudates in the middle ear, and occasionally to tympanic membrane rupture.",
"   </p>",
"   <p>",
"    A similar sequence occurs with diving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/5-11\">",
"     5-11",
"    </a>",
"    ]. The major difference is that the pressure changes encountered are usually greater, often several atmospheres of pressure change compared to the less than one atmosphere pressure change seen during flying. Large pressure differences between the middle ear and the surrounding water can lead to the same injuries as with flying. In addition, inner ear barotrauma may occur due to rupture of the round and oval membranes separating the middle and inner ear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/12\">",
"     12",
"    </a>",
"    ]. This can result in formation of a perilymphatic fistula, leading to loss of inner ear fluid with consequent hearing loss and vertigo. Although length, depth, and number of dives may be correlated with temporary changes in ear function, they are not associated with long-term problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Other causes of barotrauma include use of decompression chambers and hyperbaric oxygen chambers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/33/4633?source=see_link&amp;anchor=H7#H7\">",
"     \"Complications of scuba diving\", section on 'Ear barotrauma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dizziness from decompression sickness is thought to be due to the difference in circulation in the vestibular and auditory parts of the inner ear.&nbsp;The vestibular side has 30 percent more volume and gets four times less circulation than the cochlea. This slows any compensation to changes in gas partial pressures and makes it more susceptible to injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blast injuries have become a more prevalent cause of barotrauma with the increased incidence of war and terrorist attacks. Barotrauma results from the air pressure wave generated by an explosion. The rapid pressure change allows no time to equalize the pressure. Injuries include bruising of the eardrum, bleeding into the drum and middle ear, eardrum rupture, ossicular disruption, and inner ear injury resulting in dizziness and tinnitus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. Surgery is necessary for repair of the eardrum perforation in up to half of these barotrauma-induced perforations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Barotrauma theoretically could be induced by skydiving, because of the rapid descent, but symptoms do not seem to occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent symptom of barotrauma is pressure in the ear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. As the pressure differential increases, the pressure sensation turns to pain due to the stretching of the tympanic membrane.",
"   </p>",
"   <p>",
"    Hearing loss occurs due to deformation of the tympanic membrane and the pressure differential hindering membrane mobility. With mild pressure differences the feeling is that of having the ear blocked. As the pressure difference increases, changes occur in the tympanic membrane and middle ear that lead to greater hearing loss. Bleeding into the tympanic membrane can occur, and a serous or occasionally hemorrhagic effusion may form in the middle ear. With pressure differences greater than one atmosphere, ossicular disruption can cause a persistent conductive hearing loss and, as mentioned above, rupture of the round or oval window membranes can lead to severe vertigo and sensorineural hearing loss secondary to loss of perilymph from the inner ear.",
"   </p>",
"   <p>",
"    Any of the above injuries also may cause tinnitus. This can be pulsating or constant. The pulsating tinnitus usually resolves with resolution of the edema and serous effusion. The constant tinnitus often resolves as the ear heals, but occasionally may be permanent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of barotrauma is based upon an accurate history and a confirmatory physical examination. Any problem occurring when there is a change in surrounding pressure raises the likelihood that barotrauma has occurred. If the physical examination confirms the injury, then the diagnosis is secure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best treatment for barotrauma is avoidance. Planning for the pressure changes and if necessary medicating to prevent them can many times avoid the problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/3\">",
"     3",
"    </a>",
"    ]. Changing plans to avoid flying with a cold or canceling dives when the ears won't clear can avoid injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/12,18\">",
"     12,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of oral decongestants, antihistamines, and nasal decongestant sprays prior to flying or diving may reduce obstruction around the eustachian tube and allow for easier pressure equalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     Pseudoephedrine",
"    </a>",
"    taken 30 minutes prior to flight may reduce the incidence of barotrauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/27\">",
"     27",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/54/33632?source=see_link\">",
"     Oxymetazoline",
"    </a>",
"    is somewhat less effective. Ongoing studies are evaluating whether inhaled surfactant prior to diving could reduce Eustachian tube dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/29\">",
"     29",
"    </a>",
"    ] and whether decompression in near zero-gravity environments might effectively reduce the incidence of barotrauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Swallowing to open the eustachian tube or using the Valsalva maneuver (positive pressure against a closed nasal airway) usually equilibrates pressure in the middle ear to the outside. Doing this frequently during the change in pressure can prevent large pressure differences from forming and prevent any tissue injury. Chewing gum or sucking on hard candies helps for adults, sucking on a bottle helps for infants.",
"   </p>",
"   <p>",
"    Ear plugs have been designed that slow down the pressure changes from flying. These plugs, which are available in drug stores and most airports, allow more time to equalize the pressure change; they do not eliminate the need to equilibrate the pressure changes. Their benefit, however, has not been clearly demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/31\">",
"     31",
"    </a>",
"    ]. Ear plugs cannot be used with diving since equilibration of air pressure in the external ear canal blocked by ear plugs cannot easily occur underwater.",
"   </p>",
"   <p>",
"    Ventilation tubes can be placed in the ear to eliminate the barrier between the middle ear and the outside world. Barotrauma cannot occur in the absence of this barrier. This is an effective preventive treatment for patients undergoing hyperbaric oxygen therapy for wound healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/32\">",
"     32",
"    </a>",
"    ]. Ventilation tubes may also be considered for patients who have poor Eustachian tube function and who must fly frequently.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment of injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most injuries due to barotrauma heal with time and patience, including edematous",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemorrhagic ear drums, and serous or hemorrhagic otitis. Tympanic membrane ruptures also typically heal spontaneously if normal eustachian tube function is restored and the perforation is not secondary to a blast injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/12,18,19\">",
"     12,18,19",
"    </a>",
"    ]. Transient vestibular symptoms from repeated diving barotrauma clear over time, without long term disequilibrium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medications are of variable utility. Decongestants and antihistamines probably produce little if any change in the speed of recovery from barotrauma. Antibiotics are often mistakenly given to treat this noninfectious injury. They are indicated only when the eardrum has been ruptured and the middle ear has been contaminated. Analgesics are effective for pain relief, as necessary. There is no evidence to support the use of glucocorticoids to expedite recovery.",
"   </p>",
"   <p>",
"    Emergency situations occur when the trauma opens up the inner ear and creates a perilymphatic fistula. Loss of fluid from the inner ear can lead to dizziness (vertigo) and sensorineural hearing loss. Immediate referral should be made to an otolaryngologists to manage the injury. Bedrest and possible surgery may limit the risk for permanent hearing loss and dizziness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Surgical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery (eg, tympanoplasty or patching of the round or oval window) may be necessary for serious injuries due to inner ear barotrauma such as ossicular disruption and perilymphatic fistula. Complete bed rest with head elevation to avoid increases in cerebrospinal fluid pressure is usually indicated to decrease the leakage of perilymph [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35397/abstract/7\">",
"     7",
"    </a>",
"    ]. Sensorineural hearing loss from a perilymphatic fistula may be permanent despite early intervention. Dizziness usually resolves, but resolution may take weeks to months in severe cases.",
"   </p>",
"   <p>",
"    Myringotomy has been used as both prevention and treatment for barotrauma. The pressure differences that lead to barotrauma cannot occur with a hole in the tympanic membrane. If barotrauma has occurred, fluid can be drained to restore hearing. The difficulty with this approach has been that the myringotomy usually heals within a few days&mdash;inadequate time for most travel and inadequate time for most injuries to heal. A tube may be placed in the eardrum to keep the hole patent for a longer time. Ventilation tubes are not ideal for most cases of barotrauma (with the exception of patients undergoing hyperbaric treatment), since they stay in much longer than they are needed.",
"   </p>",
"   <p>",
"    Myringotomies with or without tubes are not appropriate for prevention of scuba diving injuries. They open the middle ear up to fluid and infection from water that can pass into the middle ear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/45/25298?source=see_link\">",
"       \"Patient information: Eustachian tube problems (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common cause of ear barotrauma is flying. Diving, decompression, hyperbaric oxygen chambers, and blast injuries are other etiologies. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Barotrauma can manifest as ear pressure, pain, hearing loss, and tinnitus. Bleeding into the tympanic membrane may occur and, rarely, rupture of the round or oval window membranes can cause vertigo and sensorineural hearing loss. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oral decongestants, antihistamines, and nasal decongestant sprays used prior to flying or diving may reduce obstruction around the eustachian tube and facilitate pressure equalization. Swallowing or the Valsalva maneuver can equalize pressures and prevent tissue injury. Chewing gum or sucking on hard candies can help adults, and infants may be helped by nursing or sucking on a bottle. Special ear plugs may help equalize pressure for flying, but cannot be used for diving. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most barotrauma injuries heal spontaneously. Antibiotics are not indicated. Analgesics should be used as needed but decongestants, antihistamines, and glucocorticoids have not been shown to be effective. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dizziness (vertigo) and sensorineural hearing loss may indicate a perilymphatic fistula and are indications for immediate referral to an otolaryngologist. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Myringotomy has been used as both prevention and treatment for barotrauma related to flying. Ventilation tubes may be needed for someone undergoing hyperbaric oxygen therapy. Tympanoplasty or patching may be needed for serious injuries such as ossicular disruption or perilymphatic fistula. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Surgical treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/1\">",
"      Sad&eacute; J, Ar A. Middle ear and auditory tube: middle ear clearance, gas exchange, and pressure regulation. Otolaryngol Head Neck Surg 1997; 116:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/2\">",
"      Argyros GJ. Management of primary blast injury. Toxicology 1997; 121:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/3\">",
"      Brown TP. Middle ear symptoms while flying. Ways to prevent a severe outcome. Postgrad Med 1994; 96:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/4\">",
"      Rosenkvist L, Klokker M, Katholm M. Upper respiratory infections and barotraumas in commercial pilots: a retrospective survey. Aviat Space Environ Med 2008; 79:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/5\">",
"      Clenney TL, Lassen LF. Recreational scuba diving injuries. Am Fam Physician 1996; 53:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/6\">",
"      Moon RE. Treatment of diving emergencies. Crit Care Clin 1999; 15:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/7\">",
"      Parell GJ, Becker GD. Conservative management of inner ear barotrauma resulting from scuba diving. Otolaryngol Head Neck Surg 1985; 93:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/8\">",
"      Parell GJ, Becker GD. Inner ear barotrauma in scuba divers. A long-term follow-up after continued diving. Arch Otolaryngol Head Neck Surg 1993; 119:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/9\">",
"      Uzun C, Adali MK, Tas A, et al. Use of the nine-step inflation/deflation test as a predictor of middle ear barotrauma in sports scuba divers. Br J Audiol 2000; 34:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/10\">",
"      Klingmann C, Praetorius M, Baumann I, Plinkert PK. Barotrauma and decompression illness of the inner ear: 46 cases during treatment and follow-up. Otol Neurotol 2007; 28:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/11\">",
"      Brocks C, Wollenberg B, Graefe H. [Acute hearing loss from scuba-diving holidays: diagnosis and treatment of barotrauma of the inner ear]. HNO 2009; 57:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/12\">",
"      Hizel SB, Muluk NB, Budak B, Budak G. Does scuba diving cause hearing loss? J Otolaryngol 2007; 36:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/13\">",
"      Goplen FK, Aasen T, Gr&oslash;nning M, et al. Hearing loss in divers: a 6-year prospective study. Eur Arch Otorhinolaryngol 2011; 268:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/14\">",
"      Fitzpatrick DT, Franck BA, Mason KT, Shannon SG. Risk factors for symptomatic otic and sinus barotrauma in a multiplace hyperbaric chamber. Undersea Hyperb Med 1999; 26:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/15\">",
"      Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ 1998; 317:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/16\">",
"      Bessereau J, Tabah A, Genotelle N, et al. Middle-ear barotrauma after hyperbaric oxygen therapy. Undersea Hyperb Med 2010; 37:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/17\">",
"      Klingmann C. Inner ear decompression sickness in compressed-air diving. Undersea Hyperb Med 2012; 39:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/18\">",
"      Tungsinmunkong S, Chongkolwatana C, Piyawongvisal W, et al. Blast injury of the ears: the experience from Yala Hospital, Southern Thailand. J Med Assoc Thai 2007; 90:2662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/19\">",
"      Ritenour AE, Wickley A, Ritenour JS, et al. Tympanic membrane perforation and hearing loss from blast overpressure in Operation Enduring Freedom and Operation Iraqi Freedom wounded. J Trauma 2008; 64:S174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/20\">",
"      Perez R, Gatt N, Cohen D. Audiometric configurations following exposure to explosions. Arch Otolaryngol Head Neck Surg 2000; 126:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/21\">",
"      Breeze J, Cooper H, Pearson CR, et al. Ear injuries sustained by British service personnel subjected to blast trauma. J Laryngol Otol 2011; 125:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/22\">",
"      Akin FW, Murnane OD. Head injury and blast exposure: vestibular consequences. Otolaryngol Clin North Am 2011; 44:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/23\">",
"      Gutovitz S, Weber K, Kaciuban S, et al. Middle ear pressure and symptoms after skydiving. Aviat Space Environ Med 2008; 79:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/24\">",
"      Sato S, Yokoi H, Fukuta S, et al. Morphological studies on middle ear barotrauma in guinea pigs. Nagoya J Med Sci 1997; 60:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/25\">",
"      Strohm M. Trauma of the middle ear. Clinical findings, postmortem observations and results of experimental studies. Adv Otorhinolaryngol 1986; 35:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/26\">",
"      Jones JS, Sheffield W, White LJ, Bloom MA. A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel. Am J Emerg Med 1998; 16:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/27\">",
"      Csortan E, Jones J, Haan M, Brown M. Efficacy of pseudoephedrine for the prevention of barotrauma during air travel. Ann Emerg Med 1994; 23:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/28\">",
"      Mirza S, Richardson H. Otic barotrauma from air travel. J Laryngol Otol 2005; 119:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/29\">",
"      Duplessis C, Fothergill D, Gertner J, et al. A pilot study evaluating surfactant on eustachian tube function in divers. Mil Med 2008; 173:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/30\">",
"      Foster PP, Butler BD. Decompression to altitude: assumptions, experimental evidence, and future directions. J Appl Physiol 2009; 106:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/31\">",
"      Klokker M, Vesterhauge S, Jansen EC. Pressure-equalizing earplugs do not prevent barotrauma on descent from 8000 ft cabin altitude. Aviat Space Environ Med 2005; 76:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/32\">",
"      Fernau JL, Hirsch BE, Derkay C, et al. Hyperbaric oxygen therapy: effect on middle ear and eustachian tube function. Laryngoscope 1992; 102:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35397/abstract/33\">",
"      Goplen FK, Gr&oslash;nning M, Aasen T, Nordahl SH. Vestibular effects of diving - a 6-year prospective study. Occup Med (Lond) 2010; 60:43.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6845 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-94DAD92080-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35397=[""].join("\n");
var outline_f34_36_35397=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EUSTACHIAN TUBE FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment of injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/33/4633?source=related_link\">",
"      Complications of scuba diving",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8458?source=related_link\">",
"      Eustachian tube dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/45/25298?source=related_link\">",
"      Patient information: Eustachian tube problems (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35398="Hydrocortisone (systemic): Patient drug information";
var content_f34_36_35398=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Hydrocortisone (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/48/8969?source=see_link\">",
"     see \"Hydrocortisone (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/46/22249?source=see_link\">",
"     see \"Hydrocortisone (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8116174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      A-Hydrocort&reg;;",
"     </li>",
"     <li>",
"      Cortef&reg;;",
"     </li>",
"     <li>",
"      Solu-CORTEF&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8116175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cortef&reg;;",
"     </li>",
"     <li>",
"      Solu-Cortef&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Addison's disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat asthma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691762",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat brain swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat COPD (chronic obstructive pulmonary disease).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling from autoimmune diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691910",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling in parts of the body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691928",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat leukemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lymphoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691999",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat organ transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat sarcoidosis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat spinal cord injuries.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ulcerative colitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to hydrocortisone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701378",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bad infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid being near anyone with chickenpox or measles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697224",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma or cataracts, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are being treated for any infection, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have soft, brittle bones (osteoporosis), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have stomach ulcers, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697345",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have TB (tuberculosis), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698138",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood sugar may cause diabetes while on this drug. This most often goes back to normal when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698236",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mood changes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697937",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in body fat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698390",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weak bones with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698252",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness, mostly in the thighs and upper arms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin changes (pimples, stretch marks, slow healing, hair growth).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697932",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cataracts or glaucoma with long-term use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been exposed to chickenpox and have not had chickenpox or had a chickenpox vaccine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695878",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take in the morning if taking once a day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take tablet with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695745",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take calcium and vitamin D as you were told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11696 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35398=[""].join("\n");
var outline_f34_36_35398=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8116174\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8116175\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031261\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031263\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031262\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031267\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031268\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031270\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031265\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031266\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031271\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031272\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?8/48/8969?source=related_link\">",
"      Hydrocortisone (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/46/22249?source=related_link\">",
"      Hydrocortisone (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/54/21352?source=related_link\">",
"      Hydrocortisone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/25/19861?source=related_link\">",
"      Hydrocortisone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/33/7702?source=related_link\">",
"      Hydrocortisone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35399="Airway foreign bodies in adults";
var content_f34_36_35399=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Airway foreign bodies in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35399/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/36/35399/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gustav Killian opened the era of bronchoscopy in 1897 when he extracted a pork bone from the trachea of a German farmer using an esophagoscope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/1\">",
"     1",
"    </a>",
"    ]. Since that time, flexible bronchoscopy has become the cornerstone of the diagnostic evaluation in adults and children with suspected foreign body aspiration (FBA). Rigid bronchoscopy remains the standard of care for removal of foreign bodies, except in selected situations. The evolution of ultrathin bronchoscopes has expanded the role of pulmonary physicians, especially pediatric pulmonologists, in the diagnosis and management patients who present with FBA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/33/37394?source=see_link\">",
"     \"Rigid bronchoscopy: Instrumentation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children, tracheobronchial FBA is a potentially life-threatening accident that may be suspected on the basis of a choking episode, if such an episode is witnessed by an adult or remembered by the child. In contrast, the clinical presentation of FBA in adults is often subtle, and diagnosis requires careful clinical assessment and the judicious use of bronchoscopy. The evaluation and treatment of FBA in adults will be reviewed here. FBA in children, central airway obstruction, and technical aspects of rigid bronchoscopy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"     \"Airway foreign bodies in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/15/7412?source=see_link\">",
"     \"Rigid bronchoscopy: Intubation techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foreign body aspiration is more common in children than in adults; approximately 80 percent of recognized cases occur in patients younger than 15 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/2\">",
"     2",
"    </a>",
"    ]. Overall, death caused by suffocation following FBA is the fifth most common cause of unintentional-injury mortality in the United States (",
"    <a class=\"graphic graphic_table graphicRef79294 \" href=\"mobipreview.htm?22/40/23179\">",
"     table 1",
"    </a>",
"    ). Over 4100 fatal episodes of FBA were reported in the United States during 2002 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/3\">",
"     3",
"    </a>",
"    ]. Children younger than one year of age and adults over the age of 75 have an increased risk of dying following FBA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tracheobronchial FBA is uncommon in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/4\">",
"     4",
"    </a>",
"    ]. Five large series have been reported, compared to dozens of publications in the pediatric literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. The largest of these, based on the clinical experience at the Mayo Clinic, identified 60 adults over a 33-year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7\">",
"     7",
"    </a>",
"    ]. Two studies from Taiwan reported 47 and 43 cases over a 13 and a 15-year period, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In our institution, FBA in adults accounts for less than 2 per thousand final diagnoses resulting from 4,500 bronchoscopies performed every year. In contrast, we diagnose 15 to 25 cases of FBA in children younger than 15 years of age annually.",
"   </p>",
"   <p>",
"    In children, nuts and other organic material account for the large majority of FB; in adults the nature of the FB is highly variable (",
"    <a class=\"graphic graphic_picture graphicRef68615 graphicRef81535 \" href=\"mobipreview.htm?40/58/41894\">",
"     picture 1A-B",
"    </a>",
"    ). Nail or pin aspiration occurs primarily in young or middle-aged adults during do-it-yourself activities. Aspiration of dental debris, appliances, or prostheses can complicate facial trauma or dental procedures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61759 graphicRef80136 \" href=\"mobipreview.htm?22/43/23218\">",
"     image 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/10\">",
"     10",
"    </a>",
"    ]. Neurologic disorders, loss of consciousness, and alcohol or sedative abuse predispose to FBA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The type of food aspirated depends on local customs. In Western, Chinese, and Middle Eastern populations, vegetable matters, bones, and watermelon seeds are the most frequently aspirated food particles, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7-9,11\">",
"     7-9,11",
"    </a>",
"    ]. One syndrome, referred to as the cafe coronary, consists of fatal or near fatal food asphyxiation caused by incompletely chewed meat (",
"    <a class=\"graphic graphic_movie graphicRef64313 \" href=\"mobipreview.htm?11/2/11296\">",
"     movie 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. This generally occurs in older patients with dentition problems, swallowing disorders, or Parkinsonism, with an estimated annual incidence of 0.66 per 100,000 population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. For practical management of acute food asphyxiation, it is crucial to remember that the FB is in a supraglottic position in about one-third of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;No prospective study has evaluated the diagnostic utility of clinical and radiographic abnormalities in adults with suspected FBA. Thus, the best available evidence is drawn from retrospective case series of confirmed FBA. Acute presentation in adults is rare, since the FB usually is wedged distally in lower lobe bronchi or the bronchus intermedius. Dyspnea is uncommon in adults with confirmed FBA, reported by only 25 percent of patients in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/8\">",
"     8",
"    </a>",
"    ]. Coughing is seen in up to 80 percent of all cases; other associated symptoms include fever, hemoptysis, chest pain, or wheeze (",
"    <a class=\"graphic graphic_algorithm graphicRef68288 \" href=\"mobipreview.htm?34/34/35374\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of FBA in adults is complicated by the fact that patients do not always volunteer or recall a history of choking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/6,8,13,17,19,20\">",
"     6,8,13,17,19,20",
"    </a>",
"    ]. The diagnosis is frequently overlooked, except when patients (or witnesses) report a typical choking episode, or in the presence of a radiopaque foreign body. Unilateral hyperinflation may be noted on the chest radiograph; however, this finding is more commonly associated with pediatric FBA (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76951 graphicRef55279 \" href=\"mobipreview.htm?25/34/26147\">",
"     image 2A-B",
"    </a>",
"    ). In a series of 19 adults who presented to the hospital with FBA, chest radiographs showed areas of consolidation, atelectasis, a tooth in the right main bronchus, and pleural effusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/21\">",
"     21",
"    </a>",
"    ]. Chest computed tomography frequently showed a radio-opaque foreign body, although it was initially missed in three patients. Other findings included atelectasis, hyperlucency consistent with air trapping, bronchiectasis, lobar consolidation, pleural effusion, hilar adenopathy, and a thickened bronchial wall adjacent to a FB.",
"   </p>",
"   <p>",
"    A foreign body may be noted unexpectedly during flexible bronchoscopy performed for symptoms of endobronchial disease, such as chronic cough, hemoptysis, asthma not responding to therapy, or recurrent",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    nonresolving pneumonia (",
"    <a class=\"graphic graphic_figure graphicRef58341 \" href=\"mobipreview.htm?25/11/25776\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef71330 \" href=\"mobipreview.htm?29/7/29811\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC FLEXIBLE BRONCHOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexible bronchoscopy has become the diagnostic procedure of choice for FBA in adults. However, the bronchoscopist performing the diagnostic procedure must be able to convert",
"    <strong>",
"     immediately",
"    </strong>",
"    to the extraction procedure using a rigid bronchoscope in the setting of complete central airway obstruction. In addition, FB removal should not be attempted during a diagnostic bronchoscopy, unless the operator is skilled in the extraction technique, and the appropriate equipment and personnel are available. In our experience, soft beans and bronchial soot plugs are the only FBs that can be removed easily using simple suction (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71658 \" href=\"mobipreview.htm?2/13/2256\">",
"     image 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Technical aspects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic flexible bronchoscopy in the setting of a suspected FBA is not technically different from diagnostic bronchoscopy performed for other indications. Flexible bronchoscopy allows precise identification and localization of FBs, facilitates the choice of rigid bronchoscope and type of forceps, and may shorten the duration of the rigid bronchoscopy procedure. The 4.9 mm outer diameter bronchoscopes with a 2.2 mm diameter working channel are used in patients older than 12 years of age. The 3.5 mm or even the 2.7 mm outer diameter bronchoscopes with 1.2 mm diameter working channels are available for younger patients (",
"    <a class=\"graphic graphic_picture graphicRef59552 \" href=\"mobipreview.htm?19/44/20161\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"     \"Airway foreign bodies in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The operator must be aware that, even in patients with stable respiratory status, clinical decompensation may occur during the diagnostic procedure due to accidental dislodgement of the FB (",
"    <a class=\"graphic graphic_figure graphicRef51718 \" href=\"mobipreview.htm?16/55/17277\">",
"     figure 2",
"    </a>",
"    ). Thus, when FBA is suspected, flexible bronchoscopy should be performed in a room equipped for resuscitation, definitive airway management, mechanical ventilation, and rigid bronchoscopy. Flexible bronchoscopy can be performed under local anesthesia in most patients; in children, we also use intravenous sedation (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    0.3",
"    <span class=\"nowrap\">",
"     mg/kg).",
"    </span>",
"    In general, patients with suspected FBA, including children, can be managed diagnostically on an outpatient basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     FOREIGN BODY REMOVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of FBA has been established, a number of factors influence the timing and choice of procedure used to remove the foreign body.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Timing of the procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchial obstruction by a FB can result in potentially serious complications, including asphyxia, hemoptysis, post-obstructive infection, and bronchiectasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7-9,19\">",
"     7-9,19",
"    </a>",
"    ]. Organic FBs, particularly those with a high oil content (such as peanuts), cause severe mucosal inflammation and accumulation of bulky granulation tissue within a few hours (",
"    <a class=\"graphic graphic_picture graphicRef68793 \" href=\"mobipreview.htm?2/7/2175\">",
"     picture 4",
"    </a>",
"    ). This also can be seen with chronically impacted sharp or rusty FBs, and following iron or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    pill aspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/22-24\">",
"     22-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once the diagnosis is established, extraction must be performed without delay. Although anesthetists usually do not like to perform general anaesthesia in subjects with uncontrolled sepsis, we do not postpone foreign body extraction (FBE) in patients with an acute post-obstructive pneumonia, since the most effective therapy in this situation is to relieve the underlying obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Role of glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a FB is completely encased in bulky and bleeding granulation tissue, extraction can be very difficult or impossible (",
"    <a class=\"graphic graphic_figure graphicRef71022 \" href=\"mobipreview.htm?26/21/26974\">",
"     figure 3",
"    </a>",
"    ). In these cases, it may be useful to postpone extraction and initiate a short course (12 to 24 hours) of intravenous glucocorticoids (1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    or equivalent), provided the patient is clinically stable. Although this practice has not been validated in prospective trials, in our experience, it usually results in dramatic resolution of the inflammatory reaction and facilitates FBE.",
"   </p>",
"   <p>",
"    Glucocorticoid therapy may result in dislodgement of the FB followed by unwitnessed expectoration and swallowing; therefore these patients should remain under observation until the extraction procedure. If there is a significant delay between diagnosis and attempted removal, it is reasonable to perform a repeat flexible bronchoscopy under local anesthesia prior to general anesthesia, in order to verify that the FB is still present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, bronchoscopy is required for FB removal in patients who present with FBA. However, in young and healthy adults with a small, movable FB (fruit pit or bead), positional maneuvers (lateral decubitus and Trendelenburg) are worth trying prior to bronchoscopy. This may result in spontaneous expectoration of the FB, or bring it into a more proximal position prior to definitive management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Rigid bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rigid bronchoscope provides excellent access to the subglottic airways, allowing gas exchange and coaxial passage of multiple instruments, including grasping forceps and a suction catheter. General anesthesia with short-acting agents, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    , is safe in this setting as procedure time rarely exceeds 10 minutes. Optical forceps allow direct visualization of the FB and optically-guided grasping (",
"    <a class=\"graphic graphic_movie graphicRef58939 \" href=\"mobipreview.htm?5/46/5870\">",
"     movie 2",
"    </a>",
"    ). Alternatively, a rigid telescope and a forceps can be used coaxially through the bronchoscope (",
"    <a class=\"graphic graphic_picture graphicRef61293 \" href=\"mobipreview.htm?14/38/14945\">",
"     picture 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/33/37394?source=see_link\">",
"     \"Rigid bronchoscopy: Instrumentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/15/7412?source=see_link\">",
"     \"Rigid bronchoscopy: Intubation techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During the extraction procedure, it is crucial not to push the FB distally with the bronchoscope, the forceps, or the suction catheter (",
"    <a class=\"graphic graphic_figure graphicRef56891 \" href=\"mobipreview.htm?30/28/31182\">",
"     figure 4",
"    </a>",
"    ). If blood and secretions are present proximal to the FB, these should be cleared by careful suctioning. Epinephrine (0.25 mg) may be instilled for hemostasis and in order to shrink the swollen mucosa encasing the FB. The optical forceps are then advanced in the bronchial axis, a few millimeters proximal to the FB.",
"   </p>",
"   <p>",
"    For smooth and rounded FBs, the key is to grip the largest volume of the FB. In this setting, the smooth forceps (foreign body forceps) are preferred to the sharp alligator forceps (",
"    <a class=\"graphic graphic_figure graphicRef56839 \" href=\"mobipreview.htm?3/37/3664\">",
"     figure 5",
"    </a>",
"    ). The forceps' cups are opened maximally and the forceps is advanced under visual control",
"    <strong>",
"     without",
"    </strong>",
"    pushing the FB downwards. The FB is then gently but securely gripped. Both forceps and FB are pulled up, a few millimeters distal to the tip of the bronchoscope, and then the instruments and FB are withdrawn",
"    <strong>",
"     en masse",
"    </strong>",
"    from the trachea. Alligator forceps are used for grasping sharp or irregular FBs (",
"    <a class=\"graphic graphic_movie graphicRef73259 \" href=\"mobipreview.htm?20/3/20542\">",
"     movie 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In case of large, hard FBs, such as pistachio shells, breaking the FB into two or three fragments may help extraction. In contrast, vigorous grasping of friable FBs, such as peanuts, should be avoided, since it may result in maceration and distal wedging of small fragments (",
"    <a class=\"graphic graphic_picture graphicRef59385 \" href=\"mobipreview.htm?5/16/5391\">",
"     picture 6",
"    </a>",
"    ). Heavy FBs, such as metallic FBs, tend to move distally due to gravity; in this setting, it may be helpful to place the patient in the Trendelenburg position. Bronchoscopic cryotherapy probes can be used in conjunction with either flexible or rigid bronchoscopes, and may also be considered in patients with organic FBA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38292?source=see_link\">",
"     \"Bronchoscopic cryosurgery: Indications, contraindications, and outcomes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During the last step of extraction, the FB can be lost accidentally, either because it is blocked in the narrow glottic area, or because there was some inappropriate coaxial movement between the bronchoscope and the forceps, causing the tip of the bronchoscope to push the FB out of the forceps' cups or jaws (",
"    <a class=\"graphic graphic_figure graphicRef61570 \" href=\"mobipreview.htm?2/29/2526\">",
"     figure 6",
"    </a>",
"    ). If this occurs, the operator should first carefully inspect the oral cavity and the larynx with the laryngoscope and grasp the FB with a Magill forceps, if possible, prior to reintubating the trachea with the bronchoscope.",
"   </p>",
"   <p>",
"    Once the FB is removed, the trachea is reintubated with the rigid bronchoscope and the airways are carefully reexamined, ideally with a flexible bronchoscope passed through the rigid tube, to rule out another FB or residual fragments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/25\">",
"     25",
"    </a>",
"    ]. When managing food asphyxiation, which is generally caused by meat, one should always be aware that in about one-third of the cases the FB is impacted at the glottic or sub-glottic level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/18\">",
"     18",
"    </a>",
"    ]. Proximally encased meat pieces can be removed with a Magill forceps or manually by sticking the middle and index fingers down the throat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Flexible bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many types of ancillary equipment (including forceps, grasping claws, snares, balloon-tipped catheters, and magnets) have been developed to allow FBE using flexible bronchoscopes (",
"    <a class=\"graphic graphic_picture graphicRef59552 \" href=\"mobipreview.htm?19/44/20161\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/2,26,27\">",
"     2,26,27",
"    </a>",
"    ]. Previously, most of the available baskets were developed for the gastrointestinal or the urinary tract. New \"zero tip\" baskets developed for endobronchial use are now available and greatly facilitate extraction of foreign bodies with the flexible bronchoscope (",
"    <a class=\"graphic graphic_picture graphicRef82405 \" href=\"mobipreview.htm?12/46/13039\">",
"     picture 7",
"    </a>",
"    ). In selected cases, flexible bronchoscopy may be used as an alternative to rigid bronchoscopy for extraction. Several authors have demonstrated that FBs, even large ones, can be effectively removed with pediatric flexible bronchoscopes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/28-36\">",
"     28-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The success rates of flexible bronchoscopic extraction in adults range from 60 to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. However, flexible extraction with specialized instruments can be cumbersome, and ultimately rigid bronchoscopy may still be required for FB removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. In addition, flexible bronchoscopy extraction entails the following risks:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When an impacted FB obstructs a mainstem bronchus, accidental migration of the FB into the contralateral lung, due to insufficient grasping with the forceps, is potentially lethal. This is less likely to occur with rigid forceps used for rigid bronchoscopy than with the forceps, grasping claws, and baskets used in conjunction with flexible bronchoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/28\">",
"       28",
"      </a>",
"      ] (",
"      <a class=\"graphic graphic_figure graphicRef51718 \" href=\"mobipreview.htm?16/55/17277\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Inflammatory lesions encasing FB are friable and may bleed when touched. Since the grasping instrument is passed through the suction port of the flexible bronchoscope, simultaneous FB manipulation and suctioning are impossible when a flexible bronchoscope is used (",
"      <a class=\"graphic graphic_figure graphicRef71022 \" href=\"mobipreview.htm?26/21/26974\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Unsuccessful attempts may push the FB distally into a wedged position (",
"      <a class=\"graphic graphic_figure graphicRef56891 \" href=\"mobipreview.htm?30/28/31182\">",
"       figure 4",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In adults and most children over the age of 12, FBE can be performed under local anesthesia using appropriately designed forceps or snares and a 4.9 mm (or greater) outer diameter flexible bronchoscope. The use of a laryngeal mask airway allows ventilation and easy access to the central airways (",
"    <a class=\"graphic graphic_picture graphicRef81776 \" href=\"mobipreview.htm?5/36/5697\">",
"     picture 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Once the FB is removed, the entire tracheobronchial tree should be checked for another FB or residual fragments. The trachea is reintubated with the rigid bronchoscope and careful examination is performed, ideally with a flexible bronchoscope passed through the rigid tube. If doubt persists, a repeat flexible bronchoscopic examination a few days later should be considered.",
"   </p>",
"   <p>",
"    We agree with other experts that flexible is",
"    <strong>",
"     superior",
"    </strong>",
"    to rigid bronchoscopy in the setting of a distally wedged FB, in mechanically ventilated patients, or in the presence of spine, craniofacial, or skull fractures that prevent the manipulation required for rigid bronchoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Perioperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controversy regarding the need for glucocorticoids or antibiotics in the perioperative management of FB aspiration results from the absence of comparative controlled studies on these issues. We use a short course of systemic glucocorticoids before FB removal when a well-tolerated FB is encased in bulky and bleeding granulation tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35399/abstract/34\">",
"     34",
"    </a>",
"    ]. However, prophylactic use of glucocorticoids to decrease the incidence of post-operative subglottic edema should be avoided. When post-operative subglottic edema occurs, parenteral glucocorticoids, aerosolized epinephrine, or helium-oxygen therapy should be considered. Antibiotics are indicated only in cases of clinically, radiologically, or bronchoscopically documented respiratory tract infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30568?source=see_link\">",
"     \"Physiology and clinical use of heliox\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/34/13858?source=see_link\">",
"       \"Patient information: Aspiration pneumonia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risk factors for foreign body aspiration (FBA) include age over 75 years, neurologic disorders, loss of consciousness, and alcohol or sedative abuse. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults, the clinical presentation of FBA is often subtle or silent, as the FB is usually wedged distally in lower lobe bronchi or the bronchus intermedius. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coughing is reported by up to 80 percent of adult patients, and dyspnea by approximately 25 percent. Other associated symptoms include fever, hemoptysis, chest pain, or wheeze (",
"      <a class=\"graphic graphic_algorithm graphicRef68288 \" href=\"mobipreview.htm?34/34/35374\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rigid bronchoscopy is the initial procedure of choice in case of asphyxiating FB. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnostic flexible bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For stable patients with more distal FBA, flexible bronchoscopy is the initial procedure of choice as it allows precise identification and localization of the FB, facilitates the choice of rigid bronchoscope and type of forceps, and sometimes allows extraction during the initial procedure. In all cases, diagnostic and therapeutic procedures should be performed by an operator skilled in both flexible and rigid bronchoscopy, in conjunction with trained assistants, and in a room equipped with full resuscitation equipment. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnostic flexible bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the diagnosis is established by flexible bronchoscopy, extraction is generally performed without delay to prevent mucosal inflammation and accumulation of granulation tissue. However, if a FB is completely encased in bulky and bleeding granulation tissue, we initiate a short course (12 to 24 hours) of intravenous glucocorticoids (1 to 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      or equivalent), provided the patient is clinically stable. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Role of glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rigid bronchoscopy, performed under general anesthesia, provides excellent access to the subglottic airways, allowing gas exchange and coaxial passage of multiple instruments, including grasping forceps and a suction catheter. Once the FB is removed, the airways are carefully reexamined, ideally with a flexible bronchoscope passed through the rigid tube, to rule out another FB or residual fragments. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Rigid bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flexible bronchoscopy is preferred over rigid bronchoscopy in certain patients, such as those with a distally wedged FB, those who are mechanically ventilated, and those with spine, craniofacial, or skull fractures that prevent the manipulation required for rigid bronchoscopy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Flexible bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many types of ancillary equipment (including forceps, grasping claws, snares, balloon-tipped catheters, and magnets) have been developed to allow FBE using flexible bronchoscopes (",
"      <a class=\"graphic graphic_picture graphicRef59552 \" href=\"mobipreview.htm?19/44/20161\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Flexible bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rarely, after FB removal, patients develop subglottic edema. This is treated with parenteral glucocorticoids, aerosolized epinephrine, and reintubation if necessary. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Perioperative management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18754356\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Charles Marquette, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/1\">",
"      Killian, G. Meeting of the Society of Physicians of Freiburg. Dec 17, 1897, Munchen Med Wschr 1989; 45:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/2\">",
"      Rafanan AL, Mehta AC. Adult airway foreign body removal. What's new? Clin Chest Med 2001; 22:319.",
"     </a>",
"    </li>",
"    <li>",
"     National Safety Council. Report on Injuries in America, 2002 Information online: www.nsc.org/library/report_injury_usa.htm (Accessed on May 03, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/4\">",
"      Baharloo F, Veyckemans F, Francis C, et al. Tracheobronchial foreign bodies: presentation and management in children and adults. Chest 1999; 115:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/5\">",
"      McGuirt WF, Holmes KD, Feehs R, Browne JD. Tracheobronchial foreign bodies. Laryngoscope 1988; 98:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/6\">",
"      Wolkove N, Kreisman H, Cohen C, Frank H. Occult foreign-body aspiration in adults. JAMA 1982; 248:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/7\">",
"      Limper AH, Prakash UB. Tracheobronchial foreign bodies in adults. Ann Intern Med 1990; 112:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/8\">",
"      Lan RS. Non-asphyxiating tracheobronchial foreign bodies in adults. Eur Respir J 1994; 7:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/9\">",
"      Chen CH, Lai CL, Tsai TT, et al. Foreign body aspiration into the lower airway in Chinese adults. Chest 1997; 112:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/10\">",
"      Weber SM, Chesnutt MS, Barton R, Cohen JI. Extraction of dental crowns from the airway: a multidisciplinary approach. Laryngoscope 2005; 115:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/11\">",
"      Elhassani NB. Tracheobronchial foreign bodies in the Middle East. A Baghdad study. J Thorac Cardiovasc Surg 1988; 96:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/12\">",
"      HAUGEN RK. THE CAF'E CORONARY. SUDDEN DEATHS IN RESTAURANTS. JAMA 1963; 186:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/13\">",
"      Eller WC, Haugen RK. Food asphyxiation--restaurant rescue. N Engl J Med 1973; 289:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/14\">",
"      Holen S, Dickler EH. Missing teeth and dentures--killers of 2,500 annually. The dentists role in the prevention and treatment of food asphyxiation. J Dist Columbia Dent Soc 1973; 48:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/15\">",
"      Feinberg MJ, Knebl J, Tully J, Segall L. Aspiration and the elderly. Dysphagia 1990; 5:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/16\">",
"      Shaker R, Ren J, Zamir Z, et al. Effect of aging, position, and temperature on the threshold volume triggering pharyngeal swallows. Gastroenterology 1994; 107:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/17\">",
"      Teramoto S, Matsuse T, Ouchi Y. Foreign body aspiration into the lower airways may not be unusual in older adults. Chest 1998; 113:1733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/18\">",
"      Mittleman RE, Wetli CV. The fatal cafe coronary. Foreign-body airway obstruction. JAMA 1982; 247:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/19\">",
"      Matsuse T, Oka T, Kida K, Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 1996; 110:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/20\">",
"      Yilmaz A, Akkaya E, Damadoglu E, Gungor S. Occult bronchial foreign body aspiration in adults: analysis of four cases. Respirology 2004; 9:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/21\">",
"      Zissin R, Shapiro-Feinberg M, Rozenman J, et al. CT findings of the chest in adults with aspirated foreign bodies. Eur Radiol 2001; 11:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/22\">",
"      Kim ST, Kaisar OM, Clarke BE, et al. 'Iron lung': distinctive bronchoscopic features of acute iron tablet aspiration. Respirology 2003; 8:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/23\">",
"      Lee P, Culver DA, Farver C, Mehta AC. Syndrome of iron pill aspiration. Chest 2002; 121:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/24\">",
"      Johnson DR, Yew D. Aspiration of nortriptyline. Am J Emerg Med 1994; 12:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/25\">",
"      Kim IG, Brummitt WM, Humphry A, et al. Foreign body in the airway: a review of 202 cases. Laryngoscope 1973; 83:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/26\">",
"      Mayr J, Dittrich S, Triebl K. A new method for removal of metallic-ferromagnetic foreign bodies from the tracheobronchial tree. Pediatr Surg Int 1997; 12:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/27\">",
"      Saito H, Saka H, Sakai S, Shimokata K. Removal of broken fragment of biopsy forceps with magnetic extractor. Chest 1989; 95:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/28\">",
"      Castro, M, Midthun, DE, Edell, ES, et al. Flexible bronchoscopic removal of foreign bodies from pediatric airways. J Bronchol 1994; 1:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/29\">",
"      Swanson KL, Prakash UB, Midthun DE, et al. Flexible bronchoscopic management of airway foreign bodies in children. Chest 2002; 121:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/30\">",
"      Monden Y, Morimoto T, Taniki T, et al. Flexible bronchoscopy for foreign body in airway. Tokushima J Exp Med 1989; 36:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/31\">",
"      Akhter J, Gaspar M, Bassuk A, Roberts J. Inadvertent removal of foreign body via a flexible fiberoptic bronchoscope in a 4-year-old boy. Pediatr Pulmonol 1994; 18:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/32\">",
"      Wood RE, Gauderer MW. Flexible fiberoptic bronchoscopy in the management of tracheobronchial foreign bodies in children: the value of a combined approach with open tube bronchoscopy. J Pediatr Surg 1984; 19:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/33\">",
"      Prakash UB, Midthun DE, Edell ES. Indications for flexible versus rigid bronchoscopy in children with suspected foreign-body aspiration. Am J Respir Crit Care Med 1997; 156:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/34\">",
"      Banerjee A, Rao KS, Khanna SK, et al. Laryngo-tracheo-bronchial foreign bodies in children. J Laryngol Otol 1988; 102:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/35\">",
"      Martinot A, Closset M, Marquette CH, et al. Indications for flexible versus rigid bronchoscopy in children with suspected foreign-body aspiration. Am J Respir Crit Care Med 1997; 155:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35399/abstract/36\">",
"      Wood, RE. Flexible bronchoscopy to remove foreign bodies in children- yes, may be- but. J Bronchol 1994; 1:87.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4387 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-79.122.249.114-3C057D9C1B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35399=[""].join("\n");
var outline_f34_36_35399=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSTIC FLEXIBLE BRONCHOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      FOREIGN BODY REMOVAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Timing of the procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Role of glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Rigid bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Flexible bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Perioperative management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18754356\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?34/34/35374\" title=\"algorithm 1\">",
"      Natural hx FBA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?3/12/3279\" title=\"diagnostic image 1A\">",
"      Tooth aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?22/40/23183\" title=\"diagnostic image 1B\">",
"      Dental plate aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/37/29279\" title=\"diagnostic image 2A\">",
"      Obstructive emphysema A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/43/32447\" title=\"diagnostic image 2B\">",
"      Obstructive emphysema B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?2/13/2256\" title=\"diagnostic image 3\">",
"      Soot plugs after airway burn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/11/25776\" title=\"figure 1\">",
"      FBA complicated by pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/55/17277\" title=\"figure 2\">",
"      Accidental loss of FB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/21/26974\" title=\"figure 3\">",
"      Hemorrhage during extraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/28/31182\" title=\"figure 4\">",
"      Iatrogenic distal impaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/37/3664\" title=\"figure 5\">",
"      Proper grasping technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/29/2526\" title=\"figure 6\">",
"      Improper coaxial movement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/20/44352\" title=\"picture 1A\">",
"      Foreign bodies A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/3/9266\" title=\"picture 1B\">",
"      Foreign bodies B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/7/29811\" title=\"picture 2\">",
"      Foreign body impacted in RLL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/44/20161\" title=\"picture 3\">",
"      Flexible bronchoscopes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/7/2175\" title=\"picture 4\">",
"      Mucosal inflammation after FBA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/38/14945\" title=\"picture 5\">",
"      Rigid bronchoscopic instruments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/16/5391\" title=\"picture 6\">",
"      Foreign body fragmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/46/13039\" title=\"picture 7\">",
"      Bronchoscopic retrieval",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/36/5697\" title=\"picture 8\">",
"      Laryngeal mask airway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?11/2/11296\" title=\"movie 1\">",
"      Central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?5/46/5870\" title=\"movie 2\">",
"      Optical forceps extraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?20/3/20542\" title=\"movie 3\">",
"      Alligator forceps extraction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4387|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/40/23179\" title=\"table 1\">",
"      Causes of unintentional death",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38292?source=related_link\">",
"      Bronchoscopic cryosurgery: Indications, contraindications, and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37351?source=related_link\">",
"      Diagnosis and management of central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38135?source=related_link\">",
"      Flexible bronchoscopy: Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/34/13858?source=related_link\">",
"      Patient information: Aspiration pneumonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30568?source=related_link\">",
"      Physiology and clinical use of heliox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/33/37394?source=related_link\">",
"      Rigid bronchoscopy: Instrumentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/15/7412?source=related_link\">",
"      Rigid bronchoscopy: Intubation techniques",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35400="Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified";
var content_f34_36_35400=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Jon C Aster, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Andrew Lister, MD, FRCP, FRCPath, FRCR",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35400/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/36/35400/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral T cell lymphomas are a heterogeneous group of generally aggressive neoplasms that constitute less than 15 percent of all non-Hodgkin lymphomas in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=see_link\">",
"     \"Classification of the hematopoietic neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among these, in decreasing frequency of occurrence, are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Peripheral T cell lymphoma, not otherwise specified",
"     </li>",
"     <li>",
"      Anaplastic large cell lymphoma, primary systemic type",
"     </li>",
"     <li>",
"      Angioimmunoblastic T cell lymphoma",
"     </li>",
"     <li>",
"      Extranodal",
"      <span class=\"nowrap\">",
"       NK/T",
"      </span>",
"      cell lymphoma, nasal type",
"     </li>",
"     <li>",
"      Subcutaneous panniculitis-like T cell lymphoma",
"     </li>",
"     <li>",
"      Enteropathy associated T cell lymphoma",
"     </li>",
"     <li>",
"      Hepatosplenic T cell lymphoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Peripheral T cell lymphoma, not otherwise specified (PTCL, NOS) is a heterogeneous group of predominantly nodal T cell lymphomas derived from various types of mature T cells that do not meet the criteria for the other specifically defined subtypes of PTCL listed above. Although PTCL, NOS accounts for the largest number of patients with PTCL in Western countries, it is likely that this group of tumors represents a conglomerate of many not yet identified PTCL subtypes.",
"   </p>",
"   <p>",
"    Although a variety of morphologic subtypes have been described, no consistent immunophenotypic, genetic, or clinical features have been associated with a large fraction of the PTCL. Therefore, for the time being, these presumably diverse cases are lumped under the heading PTCL, NOS, or \"unspecified.\" Previously, they were classified as diffuse small cleaved, mixed, large cell and immunoblastic in the Working Formulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/3,6\">",
"     3,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical presentation, pathologic features, and diagnosis of PTCL, NOS will be discussed here. The other",
"    <span class=\"nowrap\">",
"     NK/T",
"    </span>",
"    cell lymphomas and the pathobiology and treatment of the PTCLs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33065?source=see_link\">",
"     \"Initial treatment of peripheral T cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27785?source=see_link\">",
"     \"Treatment of relapsed or refractory peripheral T cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTCL, NOS is the most common subtype of PTCL in Western countries accounting for approximately 30 percent of PTCL and approximately 6 percent of non-Hodgkin lymphomas (NHLs) overall&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/3,4,7\">",
"     3,4,7",
"    </a>",
"    ]. The incidence of PTCL, NOS increased in the United States from approximately 0.1 cases per 100,000 population in 1992 to approximately 0.4 cases per 100,000 population in 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/8\">",
"     8",
"    </a>",
"    ]. This increase may reflect increased awareness and improved diagnostic methods. The incidence is higher in Asia where PTCLs account for 15 to 20 percent of all NHLs and approximately 20 to 25 percent of those cases are classified as PTCL, NOS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients are adults with a median age at diagnosis of 60 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/9\">",
"     9",
"    </a>",
"    ]. The diagnosis is more common in men with a male:female ratio of approximately 2:1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with PTCL, NOS present with generalized lymphadenopathy with or without extranodal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Approximately 38 percent of patients have nodal disease alone, 49 percent have nodal and extranodal disease, and 13 percent have extranodal disease without evidence of nodal involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ]. Hepatomegaly and splenomegaly are seen in 17 and 24 percent of patients, respectively. Approximately 14, 17, 26, and 43 percent of cases are stage I, II, III, and IV, respectively. The bone marrow is involved in 20 percent of cases and many others demonstrated infiltration of the liver",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spleen. While circulating lymphoma cells may be seen, a leukemic presentation is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4\">",
"     4",
"    </a>",
"    ]. Some cases demonstrate blood eosinophilia, pruritus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemophagocytosis (",
"    <a class=\"graphic graphic_picture graphicRef52783 \" href=\"mobipreview.htm?32/2/32806\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/12\">",
"     12",
"    </a>",
"    ]. Thrombocytopenia and anemia are seen in one-quarter of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skin and gastrointestinal tract are the most commonly involved extranodal sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4,13-15\">",
"     4,13-15",
"    </a>",
"    ]. Less commonly involved sites include the lung, salivary gland, and central nervous system. Systemic B symptoms (fever, night sweats, weight loss) are present in approximately 35 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ]. Half of cases are associated with an elevated lactate dehydrogenase level and 14 percent have hypergammaglobulinemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/37/14935?source=see_link&amp;anchor=H13#H13\">",
"     \"Staging and prognosis of Hodgkin lymphoma\", section on 'Criteria for B symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTCL, NOS is a heterogeneous group of tumors comprised of malignant cells of T cell origin with varied histology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymph nodes usually demonstrate effacement of the normal architecture by sheets of atypical lymphoid cells in a paracortical or diffuse pattern (",
"    <a class=\"graphic graphic_picture graphicRef83591 \" href=\"mobipreview.htm?23/37/24153\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4\">",
"     4",
"    </a>",
"    ]. The tumor cells have no characteristic morphologic features and typically are comprised of variable mixtures of small, intermediate, and large atypical cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. These cells contain pleomorphic, irregular, vesicular, or hyperchromatic nuclei with prominent nucleoli and are associated with numerous mitotic figures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4\">",
"     4",
"    </a>",
"    ]. They sometimes have a clear cytoplasm, a morphologic feature suggestive of a T cell phenotype.",
"   </p>",
"   <p>",
"    Typically, there are varying numbers of admixed eosinophils, plasma cells, resting or activated, B cells, and epithelioid histiocytes (activated macrophages) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/18\">",
"     18",
"    </a>",
"    ]; the term lymphoepithelioid cell lymphoma (Lennert's lymphoma) has been used in the past for cases rich in epithelioid histiocytes (",
"    <a class=\"graphic graphic_picture graphicRef83592 \" href=\"mobipreview.htm?30/24/31112\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/18\">",
"     18",
"    </a>",
"    ], and is considered a variant form of PTCL, NOS.",
"   </p>",
"   <p>",
"    Two additional variants include a form characterized by a growth pattern in the paracortex throughout the node surrounding residual reactive follicles, the so-called &ldquo;T-zone&rdquo; variant, and another with the malignant T cells growing in aggregates within follicles, the so-called &ldquo;follicular&rdquo; variant.",
"   </p>",
"   <p>",
"    Biopsy of involved extranodal tissues demonstrates a diffuse infiltrate of similar atypical lymphoid cells. Skin involvement commonly infiltrates the dermis and subcutis and can result in nodules with central ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/1\">",
"     1",
"    </a>",
"    ]. Splenic involvement can vary from solitary fleshy nodules to diffuse involvement of the white or red pulp [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Immunophenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no characteristic immunophenotype for PTCL, NOS. T cell-associated antigens are variably expressed",
"    <span class=\"nowrap\">",
"     (CD3+/-,",
"    </span>",
"    <span class=\"nowrap\">",
"     CD2+/-,",
"    </span>",
"    <span class=\"nowrap\">",
"     CD5+/-,",
"    </span>",
"    <span class=\"nowrap\">",
"     CD7-/+).",
"    </span>",
"    These tumors do not express B cell associated antigens (eg, CD20) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/17,19\">",
"     17,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most cases, one or more \"mature\" T cell antigens is lost, such as CD5 or CD7. Expression of CD4 and CD8 is variable. The majority of tumors express CD4 only, but some tumors may be",
"    <span class=\"nowrap\">",
"     CD4-/CD8-,",
"    </span>",
"    <span class=\"nowrap\">",
"     CD4-/CD8+,",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     CD4+/CD8+.",
"    </span>",
"    Most cases express",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    T cell receptors (TCR beta positive), while a minority express",
"    <span class=\"nowrap\">",
"     gamma/delta",
"    </span>",
"    T cell receptors (TCR gamma-positive).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genetic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clonal T cell receptor (TCR) gene rearrangements are usually, but not always, detected; immunoglobulin (Ig) genes are germline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Although approximately 90 percent of PTCLs demonstrate cytogenetic abnormalities, none is specific for PTCL, NOS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/22-27\">",
"     22-27",
"    </a>",
"    ]. Many patients demonstrate chromosomal gains in 7q, 8q, 17q, and 22q, and chromosomal losses in 4q, 5q, 6q, 9p, 10q, 12q, and 13q [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common translocations are t(7;14), t(11;14), inv(14), and t(14;14) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/28\">",
"     28",
"    </a>",
"    ]. Analogous to B cell lymphomas where immunoglobulin (Ig) loci (BCR genes) are affected, these translocations involve genes for the TCR at 14q11, 7q34-35, and 7p15. However, translocations involving the TCR genes in PTCLs are much less frequent than translocations involving the Ig genes in B cell lymphomas. This is likely due to the fact that mature B cells continue to diversify their Ig genes in germinal centers through somatic hypermutation and class switching, events that are prone to errors that can result in translocations, whereas the TCR genes of mature T cells are genomically stable and presumably much less likely to participate in oncogenic rearrangements.",
"   </p>",
"   <p>",
"    Efforts are underway to use genomic profiling and other techniques to further divide this heterogeneous group of tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. Gene expression profiles (GEPs) of PTCL, NOS are clearly distinct from resting normal T cells, and are most closely related to activated CD4+ or CD8+ peripheral T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/33\">",
"     33",
"    </a>",
"    ]. In addition, PTCL, NOS, angioimmunoblastic T cell lymphoma, and anaplastic large cell lymphoma have distinctive gene expression profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTCL, NOS is a diagnosis made based upon the results of a tissue biopsy (usually lymph node biopsy) that demonstrates evidence of a T cell lymphoma that does not meet the criteria for other subtypes of T cell lymphoma including (",
"    <a class=\"graphic graphic_table graphicRef55385 \" href=\"mobipreview.htm?5/61/6109\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anaplastic large cell lymphoma",
"     </li>",
"     <li>",
"      Angioimmunoblastic T cell lymphoma",
"     </li>",
"     <li>",
"      Extranodal",
"      <span class=\"nowrap\">",
"       NK/T",
"      </span>",
"      cell lymphoma, nasal type",
"     </li>",
"     <li>",
"      Subcutaneous panniculitis-like T cell lymphoma",
"     </li>",
"     <li>",
"      Enteropathy associated T cell lymphoma",
"     </li>",
"     <li>",
"      Hepatosplenic T cell lymphoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As described above, histologic examination of the biopsy material usually demonstrates variable mixtures of small, intermediate, and large atypical cells. In many instances, the histologic features are sufficiently atypical (eg, complete nodal effacement by atypical lymphoid cells) that a diagnosis of lymphoma can be made with certainty, but evaluation of the immunophenotype by either immunohistochemistry or flow cytometry is essential to confirm the T cell origin of the tumor. Immunohistochemistry is more reliable, because large lymphoid cells are sometimes lost or disrupted during tissue processing required for performance of flow cytometry.",
"   </p>",
"   <p>",
"    The immunophenotype of PTCL, NOS varies greatly from case to case, but always demonstrates expression of one or more of the pan-T antigens (ie, CD2, CD3, CD5, CD7). Roughly half of cases demonstrate an aberrant immunophenotype, defined by the loss of a pan-T cell antigen that is expressed by most normal mature T cells (eg, CD5 or CD7) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Detection of surface CD3 (best assessed by flow cytometry) can also be helpful, since this finding excludes rare lymphomas of natural killer cell origin. In difficult or equivocal cases, molecular detection of a clonal T cell receptor (TCR) rearrangement, performed using a PCR-based assay, can be very helpful. While the majority of PTCL, NOS has cytogenetic abnormalities, none are specific.",
"   </p>",
"   <p>",
"    Because PTCL, NOS is a heterogeneous category and essentially a diagnosis of exclusion, the diagnostic agreement rate among expert hematopathologists is only about 75 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ]. As with other T cell lymphomas, knowledge of pertinent clinical and laboratory findings improves diagnostic accuracy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of PTCL, NOS includes other T cell lymphomas and B cell lymphomas (including Hodgkin lymphoma) that have similar morphologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunophenotypic features, and benign disorders that result in hyperplasia of nodal paracortical T cell zones, such as hypersensitivity reactions and unusually prolonged or robust immune responses to viral infections (eg, with Epstein Barr virus) (",
"    <a class=\"graphic graphic_table graphicRef55385 \" href=\"mobipreview.htm?5/61/6109\">",
"     table 1",
"    </a>",
"    ). Thin needle biopsies can be particularly difficult to interpret as architectural effacement cannot be assessed, and the malignant mixed cell infiltrate can mimic a reactive process. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/61/27610?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Type of biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Angioimmunoblastic T cell lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angioimmunoblastic T cell lymphoma (AITL) is another relatively common subtype of T cell lymphoma that presents with generalized lymphadenopathy and systemic symptoms. Like PTCL, NOS, involved lymph nodes demonstrate partial or complete effacement of the normal architecture by a predominantly paracortical infiltrate of atypical lymphoid cells of different sizes and inflammatory cells. There is prominent neovascularization with arborizing high endothelial venules and an expansion of follicular dendritic cells that often surround tumor cells with abundant clear cytoplasm. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/14/34023?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of angioimmunoblastic T cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The distinction between PTCL, NOS and AITL is based upon the absence of morphologic features typical of AITL and the immunophenotype of the tumor cells. Unlike AITL, the tumor cells in PTCL, NOS do not typically express CD10, BCL6, PD1, or CXCL13 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Anaplastic large cell lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaplastic large cell lymphoma (ALCL) is a lymphoma of T cell or null cell type that typically presents with painless lymphadenopathy with or without systemic symptoms. On histology, the tumor is composed in part by large lymphoma cells with horseshoe-shaped nuclei and prominent nucleoli (hallmark cells). ALCL demonstrates homogeneous, strong expression of CD30 in a membrane and golgi pattern. T cell antigens are also commonly expressed.",
"   </p>",
"   <p>",
"    A proportion of PTCL, NOS tumors express CD30 in a subset of cells, but not in the diffuse pattern typical of ALCL. ALCL is often positive for epithelial membrane antigen and ALK, the latter due to the presence of ALK gene rearrangements, all of which are absent from PTCL, NOS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/47/25337?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of anaplastic large cell lymphoma, ALK positive\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to note that anaplastic large cell lymphoma that is ALK-negative is not always easily distinguished from CD30+ PTCL, NOS, and for this reason is considered a provisional entity in the WHO 2008 classification scheme.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hodgkin lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both PTCL, NOS and classical Hodgkin lymphoma (HL) may contain cells resembling Reed-Sternberg cells in an inflammatory background. Uncommonly, PTCL, NOS can express CD30 and rarely are positive for CD15, markers that are typically positive in classical forms of HL. However, PTCL, NOS is differentiated from HL by the absence of PAX5, a B cell-specific factor seen in most cases of HL, and by the expression of",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    T cell receptors (TCR beta positive) and other T cell markers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15578?source=see_link\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adult T cell leukemia-lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult T cell leukemia-lymphoma (ATL) is another T cell lymphoma that typically presents with generalized lymphadenopathy, hepatosplenomegaly, immunosuppression, hypercalcemia, lytic bone lesions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    skin lesions. The malignant cell of origin in ATL is a transformed HTLV-I infected mature helper (CD4+) T-lymphocyte. Nodal ATL cannot be reliably distinguished from PTCL, NOS on morphologic or immunophenotypic grounds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ] and can only be excluded with certainty if HTLV-I studies (generally serology) are negative, particularly in patients from regions where HTLV-1 is endemic. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9945?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of adult T cell leukemia-lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     T cell histiocyte rich large B cell lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;T cell histiocyte rich large B cell lymphoma (THRLBCL) is a variant of diffuse large B cell lymphoma (DLBCL) that can resemble PTCL, NOS. In THRLBCL, the tumor cells are a minor fraction of the total cellularity, which consists mainly of reactive T cells and histiocytes. Distinction from PTCL, NOS is usually not difficult, as the malignant B cells in THRLBCL express pan B cell markers (eg, CD19, CD20, CD22, CD79a), and will usually show IgH gene rearrangements. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=see_link&amp;anchor=H21#H21\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\", section on 'T cell histiocyte rich large B cell lymphoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Benign paracortical hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases of PTCL, NOS demonstrate a perifollicular (T-zone) growth pattern that is similar to that seen in benign paracortical hyperplasia. These two entities can be distinguished by the molecular detection of clonal T cell receptor rearrangements in PTCL, NOS, typically by polymerase chain reaction-based assays. Care must be taken not to over-interpret a dominant clone within a reactive T cell expansion in small biopsy specimens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of PTCL, NOS is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33065?source=see_link\">",
"     \"Initial treatment of peripheral T cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27785?source=see_link\">",
"     \"Treatment of relapsed or refractory peripheral T cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of PTCL, NOS is aggressive, and relapses are common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/7,10,37-40\">",
"     7,10,37-40",
"    </a>",
"    ]. Both disease stage at diagnosis and the international prognostic index (IPI) score used for other non-Hodgkin lymphomas (NHLs) have correlated with overall survival in these patients (",
"    <a class=\"graphic graphic_table graphicRef70850 \" href=\"mobipreview.htm?17/21/17757\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/41\">",
"     41",
"    </a>",
"    ]. Patients with PTCL generally have a worse prognosis, stage for stage, than patients with B cell NHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/15,38,42\">",
"     15,38,42",
"    </a>",
"    ]. However, some patients may attain long term survival with treatment that incorporates transplantation (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33065?source=see_link\">",
"     \"Initial treatment of peripheral T cell lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29127?source=see_link&amp;anchor=H17219017#H17219017\">",
"     \"Prognosis of diffuse large B cell lymphoma\", section on 'International Prognostic Index'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Prior to the routine use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    for B cell NHL, a retrospective analysis compared the ability of the IPI to predict outcomes in 288 patients with PTCL and 1595 patients with B cell NHL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/42\">",
"     42",
"    </a>",
"    ]. When compared with patients with B cell NHL, patients with PTCL demonstrated the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A similar distribution of IPI scores. For all patients with PTCL, IPI scores of zero, 1, 2, and &ge;3 were seen in 13, 17, 24, and 45 percent, respectively. However, the distribution varied by PTCL subtype. When compared with other subtypes of PTCL, patients with anaplastic large cell lymphoma (20 percent of the total) were more likely to have an IPI of zero (39 versus 7 percent) or 1 (24 versus 15 percent).",
"     </li>",
"     <li>",
"      Similar five-year overall survival rates for patients with IPI scores of zero (82 versus 81 percent) or 1 (73 versus 71 percent).",
"     </li>",
"     <li>",
"      Worse five-year overall survival rates for patients with IPI scores of 2 (58 versus 63 percent) or &ge;3 (35 versus 52 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other prognostic scoring systems have been proposed, but require further validation. The most popular of these, the prognostic index for PTCL, unspecified (PIT) assigns one point for each of the following criteria (",
"    <a class=\"graphic graphic_table graphicRef72901 \" href=\"mobipreview.htm?9/15/9467\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &gt;60 years",
"     </li>",
"     <li>",
"      Increased serum lactate dehydrogenase",
"     </li>",
"     <li>",
"      Eastern Cooperative Oncology Group (ECOG) performance status &ge;2",
"     </li>",
"     <li>",
"      Bone marrow involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A retrospective multicenter study of 385 patients with PTCL, NOS was used to develop this prognostic score and demonstrated an association between increased score and decreased survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/43\">",
"     43",
"    </a>",
"    ]. Patients with zero, one, two, or three to four of these adverse prognostic factors had five-year overall survival rates of 63, 53, 33, and 18 percent, respectively. A second retrospective analysis of a smaller population also found the PIT score to correlate with progression-free and overall survival rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/44\">",
"     44",
"    </a>",
"    ]. However, when applied to another cohort of 340 cases of PTCL, NOS, the PIT was not superior to the IPI for predicting survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another system, the International peripheral T cell lymphoma Project score (IPTCLP), incorporates information on age (&le;60 versus &gt;60), ECOG performance score (&le;1 versus &gt;1), and platelet count (&le;150K versus &gt;150K) to divide patients into four groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/45\">",
"     45",
"    </a>",
"    ]. When applied to 121 patients with PTCL, patients with zero, 1, 2, or 3 risk factors demonstrated five-year overall survival rates of 58, 15, 5, and zero percent, respectively.",
"   </p>",
"   <p>",
"    Other models have suggested the following features as potential predictors of a poor response: Ki-67 positivity of &ge;80 percent, Epstein-Barr virus positivity, the presence of systemic B symptoms, low albumin, mediastinal lymphadenopathy, and in the presence of a \"proliferation signature\" by gene expression profiling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35400/abstract/44,46-50\">",
"     44,46-50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral T cell lymphoma, not otherwise specified (PTCL, NOS) is a heterogeneous group of predominantly nodal T cell lymphomas that do not meet the criteria for the other specifically defined subtypes of PTCL.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PTCL, NOS is the most commonly diagnosed type of PTCL in Western countries accounting for approximately 30 percent of cases. The incidence varies geographically with the highest incidence found in Asia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients present with generalized lymphadenopathy with or without extranodal disease. Systemic B symptoms are common and some cases demonstrate blood eosinophilia, pruritus,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemophagocytosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PTCL, NOS is a diagnosis of exclusion made based upon the results of a tissue biopsy (usually lymph node biopsy) that demonstrates evidence of a T cell lymphoma that does not meet the criteria for other subtypes of T cell lymphoma (",
"      <a class=\"graphic graphic_table graphicRef55385 \" href=\"mobipreview.htm?5/61/6109\">",
"       table 1",
"      </a>",
"      ). Evaluation of the immunophenotype by either immunohistochemistry or flow cytometry is essential to confirm the T cell origin of the tumor. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Histology usually demonstrates a non-specific mixture of small, intermediate, and large atypical cells (",
"      <a class=\"graphic graphic_picture graphicRef83591 \" href=\"mobipreview.htm?23/37/24153\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Histology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The immunophenotype of PTCL, NOS, varies greatly from case to case, but always demonstrates expression of one or more of the pan-T antigens (ie, CD2, CD3, CD5, CD7). Roughly half of cases demonstrate an aberrant immunophenotype, defined by the loss of a pan-T cell antigen that is expressed by all normal mature T cells (eg, CD5 or CD7). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Immunophenotype'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of PTCL, NOS includes other T cell lymphomas and B cell lymphomas (including Hodgkin lymphoma) that have a similar morphology",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      immunophenotype. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical course of PTCL, NOS is aggressive, and if remission is achieved, relapses are common. Both disease stage at diagnosis and the international prognostic index (IPI) score used for other NHLs have correlated with overall survival in these patients (",
"      <a class=\"graphic graphic_table graphicRef70850 \" href=\"mobipreview.htm?17/21/17757\">",
"       table 2",
"      </a>",
"      ). Patients with PTCL generally have a worse prognosis, stage for stage, than patients with B cell non-Hodgkin lymphoma. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/1\">",
"      Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/2\">",
"      Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/3\">",
"      Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16:2780.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/5\">",
"      Rizvi MA, Evens AM, Tallman MS, et al. T-cell non-Hodgkin lymphoma. Blood 2006; 107:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/6\">",
"      Medeiros LJ, Lardelli P, Stetler-Stevenson M, et al. Genotypic analysis of diffuse, mixed cell lymphomas. Comparison with morphologic and immunophenotypic findings. Am J Clin Pathol 1991; 95:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/7\">",
"      A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89:3909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/8\">",
"      Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008; 49:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/9\">",
"      Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26:4124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/10\">",
"      Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 2011; 117:3402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/11\">",
"      Dogan A, Morice WG. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol 2004; 127:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/12\">",
"      Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990; 75:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/13\">",
"      Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 1992; 141:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/14\">",
"      Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/15\">",
"      Bekkenk MW, Vermeer MH, Jansen PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood 2003; 102:2213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/16\">",
"      Suchi T, Lennert K, Tu LY, et al. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 1987; 40:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/17\">",
"      Weiss LM, Crabtree GS, Rouse RV, Warnke RA. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 1985; 118:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/18\">",
"      Patsouris E, No&euml;l H, Lennert K. Histological and immunohistological findings in lymphoepithelioid cell lymphoma (Lennert's lymphoma). Am J Surg Pathol 1988; 12:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/19\">",
"      Borowitz MJ, Reichert TA, Brynes RK, et al. The phenotypic diversity of peripheral T-cell lymphomas: the Southeastern Cancer Study Group experience. Hum Pathol 1986; 17:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/20\">",
"      Weiss LM, Trela MJ, Cleary ML, et al. Frequent immunoglobulin and T-cell receptor gene rearrangements in \"histiocytic\" neoplasms. Am J Pathol 1985; 121:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/21\">",
"      Weiss LM, Picker LJ, Grogan TM, et al. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 1988; 130:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/22\">",
"      Boehm T, Baer R, Lavenir I, et al. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 1988; 7:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/23\">",
"      Caccia N, Bruns GA, Kirsch IR, et al. T cell receptor alpha chain genes are located on chromosome 14 at 14q11-14q12 in humans. J Exp Med 1985; 161:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/24\">",
"      Caccia N, Kronenberg M, Saxe D, et al. The T cell receptor beta chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell 1984; 37:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/25\">",
"      Hecht F, Morgan R, Hecht BK, Smith SD. Common region on chromosome 14 in T-cell leukemia and lymphoma. Science 1984; 226:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/26\">",
"      Kaneko Y, Maseki N, Homma C, et al. Chromosome translocations involving band 7q35 or 7p15 in childhood T-cell leukemia/lymphoma. Blood 1988; 72:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/27\">",
"      Schlegelberger B, Himmler A, G&ouml;dde E, et al. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 1994; 83:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/28\">",
"      Ong ST, Le Beau MM. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Semin Oncol 1998; 25:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/29\">",
"      Hartmann S, Gesk S, Scholtysik R, et al. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol 2010; 148:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/30\">",
"      Agostinelli C, Piccaluga PP, Went P, et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol 2008; 61:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/31\">",
"      Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/32\">",
"      Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012; 120:2280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/33\">",
"      Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007; 117:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/34\">",
"      de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109:4952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/35\">",
"      Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 1989; 42:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/36\">",
"      Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease. Clinical, pathologic, and immunologic features of 78 cases. Cancer 1990; 65:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/37\">",
"      Weisenburger DD, Linder J, Armitage JO. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. Hematol Oncol 1987; 5:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/38\">",
"      Coiffier B, Brousse N, Peuchmaur M, et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1990; 1:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/39\">",
"      Armitage JO, Greer JP, Levine AM, et al. Peripheral T-cell lymphoma. Cancer 1989; 63:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/40\">",
"      Lippman SM, Miller TP, Spier CM, et al. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988; 72:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/41\">",
"      Schmitz N, Tr&uuml;mper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 2010; 116:3418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/42\">",
"      Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/43\">",
"      Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103:2474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/44\">",
"      Lee Y, Uhm JE, Lee HY, et al. Clinical features and prognostic factors of patients with \"peripheral T cell lymphoma, unspecified\". Ann Hematol 2009; 88:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/45\">",
"      Guti&eacute;rrez-Garc&iacute;a G, Garc&iacute;a-Herrera A, Cardesa T, et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 2011; 22:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/46\">",
"      Went P, Agostinelli C, Gallamini A, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006; 24:2472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/47\">",
"      Dupuis J, Emile JF, Mounier N, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006; 108:4163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/48\">",
"      Chihara D, Oki Y, Ine S, et al. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk Lymphoma 2009; 50:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/49\">",
"      Cuadros M, Dave SS, Jaffe ES, et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007; 25:3321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35400/abstract/50\">",
"      Valleron W, Ysebaert L, Berquet L, et al. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood 2012; 120:3997.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4694 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-97C5FA2E12-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35400=[""].join("\n");
var outline_f34_36_35400=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Immunophenotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genetic features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Angioimmunoblastic T cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Anaplastic large cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adult T cell leukemia-lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      T cell histiocyte rich large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Benign paracortical hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4694\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4694|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/2/32806\" title=\"picture 1\">",
"      T cell NHL hemophagocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/37/24153\" title=\"picture 2\">",
"      PTCL-NOS histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/24/31112\" title=\"picture 3\">",
"      PTCL NOS pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4694|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/61/6109\" title=\"table 1\">",
"      PTCL path",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/21/17757\" title=\"table 2\">",
"      Int prognostic index NHL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/15/9467\" title=\"table 3\">",
"      ECOG performance scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21337?source=related_link\">",
"      Classification of the hematopoietic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9945?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of adult T cell leukemia-lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/47/25337?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of anaplastic large cell lymphoma, ALK positive",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/14/34023?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of angioimmunoblastic T cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/13/15578?source=related_link\">",
"      Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33065?source=related_link\">",
"      Initial treatment of peripheral T cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29127?source=related_link\">",
"      Prognosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/37/14935?source=related_link\">",
"      Staging and prognosis of Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27785?source=related_link\">",
"      Treatment of relapsed or refractory peripheral T cell lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35401="Vaginal hysterectomy";
var content_f34_36_35401=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vaginal hysterectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Thomas G Stovall, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     William J Mann, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Howard T Sharp, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/36/35401/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/36/35401/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysterectomy (surgical removal of the uterus) may be performed via an abdominal, vaginal, or laparoscopically-assisted vaginal approach. Once the decision has been made to proceed with hysterectomy, the physician must decide upon the route, which depends upon clinical circumstances and the surgeon's technical expertise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=see_link\">",
"     \"Overview of hysterectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues related to vaginal hysterectomy will be reviewed here. Other hysterectomy procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=see_link\">",
"     \"Abdominal hysterectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/22/14698?source=see_link\">",
"     \"Laparoscopic approach to hysterectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS AND ALTERNATIVES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for and alternatives to hysterectomy are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=see_link\">",
"     \"Overview of hysterectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reason for the hysterectomy, risks and benefits of the procedure, alternatives, and expectations for outcome, should be discussed with the woman in detail. Few procedures for benign disease engender as much patient anxiety and concern as hysterectomy. There are a number of indications for hysterectomy that are based more upon opinion than evidence from well-designed studies. In these situations, informed consent with thorough exploration of patient preferences and expectations is most important.",
"   </p>",
"   <p>",
"    Education during the preoperative visit is one of the most important means of ensuring the patient's acceptance and compliance during the immediate postoperative period. Women are provided with positive statements about what to expect postoperatively and regarding return to normal activities along with a standard surgical informed consent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The issue of elective oophorectomy should also be addressed during the preoperative visit. The risks and benefits of elective oophorectomy at the time of hysterectomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/21/15706?source=see_link&amp;anchor=H21231548#H21231548\">",
"     \"Elective oophorectomy or ovarian conservation at the time of hysterectomy\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A prophylactic antibiotic agent is given as a single intravenous (IV) dose 30 minutes prior to the first incision for hysterectomy and should be repeated if the procedure extends beyond four hours or if blood loss is greater than 1500 mL. Repeat dosing after wound closure is not necessary. Appropriate antibiotic options include first and second generation cephalosporins (",
"    <a class=\"graphic graphic_table graphicRef87199 \" href=\"mobipreview.htm?0/45/733\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A detailed discussion of prevention of gynecologic surgical site (ie, wound) infection, including alternative antibiotic choices for patients with beta-lactam allergy, can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women with bacterial vaginosis, randomized trial data show that treatment of bacterial vaginosis for eight days, starting four days before surgery, can reduce the frequency of vaginal cuff [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H17#H17\">",
"     \"Bacterial vaginosis\", section on 'Gynecologic procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     OPERATIVE PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The surgical technique of any individual surgeon varies between cases, evolves with experience, and is dependent upon the pathologic conditions or anatomic variations encountered. The procedure presented below is a step-by-step approach that works well for most cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Initial steps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient positioning in dorsal lithotomy is critical to obtain optimal exposure. When adequate anesthesia is obtained, a bimanual pelvic examination is performed to confirm the findings of the office examination, to assess uterine mobility and descent, and to confirm that no unsuspected adnexal pathology is found. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=see_link\">",
"     \"Pelvic examination under anesthesia\"",
"    </a>",
"    .) A final decision can then be made whether to proceed with a vaginal or abdominal approach.",
"   </p>",
"   <p>",
"    The patient is prepared and draped. In our opinion, a distended bladder helps in the recognition of a bladder injury, but it is also reasonable to insert a bladder catheter. A weighted speculum is placed into the posterior vagina, a Deaver or right angle retractor is positioned anterior to the cervix and then the anterior and posterior lips of the cervix are grasped with a single- or double-toothed tenaculum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/34/38440?source=see_link\">",
"     \"Surgical instruments for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vasopressin (10 to 20 units in 50-mL saline) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    (0.5 percent) may be injected into the cervical, paracervical, and submucosal tissues to help identify tissue planes and reduce blood loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, vasoconstrictive agents are not required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hysterectomy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traction is placed on the cervix to expose the posterior vaginal epithelium. The posterior cul-de-sac (pouch of Douglas) is grasped with a single tooth forceps, incised with Mayo scissors, and the peritoneum identified (",
"    <a class=\"graphic graphic_figure graphicRef66673 \" href=\"mobipreview.htm?27/43/28339\">",
"     figure 1",
"    </a>",
"    ). A common error is to make exceedingly small cuts into the tented-up posterior peritoneum, as opposed to a generous bite. A figure-of-eight suture is then taken to attach the peritoneum to the posterior vaginal epithelium. If difficulty is encountered isolating the posterior peritoneum, the vaginal epithelium may be incised vertically to the point at which the posterior cul-de-sac becomes more apparent. If vaginal mucosal dissection has occurred in the wrong plane, the hysterectomy may be begun in an extraperitoneal fashion by clamping and cutting the uterosacral and cardinal ligaments close to the cervix. If these steps fail, the anterior peritoneum can be entered and the posterior peritoneum identified by placing a finger or instrument behind the uterus.",
"   </p>",
"   <p>",
"    Entry into the posterior cul-de-sac may not be possible as an initial step if endometriosis or extensive adhesive disease caused by previous surgery or pelvic inflammatory disease have obliterated the posterior cul-de-sac. In these cases, one can continue",
"    <span class=\"nowrap\">",
"     clamping/ligation",
"    </span>",
"    of the uterosacral and cardinal ligaments until entry into the posterior cul-de-sac becomes possible.",
"   </p>",
"   <p>",
"    Alternatively, some surgeons prefer to make a circumferential incision in the vaginal epithelium at the junction of the cervix just below the bladder reflection, rather than directly entering the posterior cul-de-sac. The vaginal epithelium may be dissected sharply to the underlying tissue or may be pushed bluntly, using a rolling motion, with an open sponge over the index finger. If the initial incision is made too close to the external cervical os, there is a greater amount of dissection required and associated bleeding. The exposed posterior peritoneum is then incised with a generous bite using Mayo scissors.",
"   </p>",
"   <p>",
"    A Steiner-Anvard weighted speculum is inserted into the posterior cul-de-sac after this space is opened. The uterosacral ligaments are clamped, with the tip of the clamp incorporating the lower portion of the cardinal ligaments (",
"    <a class=\"graphic graphic_figure graphicRef76088 \" href=\"mobipreview.htm?27/30/28130\">",
"     figure 2",
"    </a>",
"    ). The clamp is placed perpendicular to the uterine axis, and the pedicle cut so that there is approximately 0.5 cm of tissue distal to the clamp. Leaving too much tissue increases the risk of infection when this tissue becomes necrotic. A transfixion suture is then placed at the tip of the clamp. Once ligated, the uterosacral ligaments are transfixed to the posterior lateral vaginal epithelium to further support the vagina and provide hemostasis (",
"    <a class=\"graphic graphic_figure graphicRef72050 \" href=\"mobipreview.htm?22/6/22626\">",
"     figure 3",
"    </a>",
"    ). This suture may be held with a hemostat to facilitate location of any bleeding at the completion of the procedure and to aid in vaginal closure. An alternative approach is to suture the uterosacral ligaments to the internal vagina and then tie and cut the suture without holding it in place. A third approach is to suture ligate the uterosacral pedicles and use one end of the suture to run along the posterior vaginal cuff. Cutting sutures avoids clutter and entanglement in the operative field. The two suture ends are then tied in the midline. These methods illustrate various techniques that can be used to accomplish the same objective.",
"   </p>",
"   <p>",
"    Downward traction is placed on the cervix to provide countertraction for the vaginal epithelium and the anterior vaginal epithelium is incised at the level of the cervicovaginal junction (",
"    <a class=\"graphic graphic_figure graphicRef60619 \" href=\"mobipreview.htm?26/58/27555\">",
"     figure 4",
"    </a>",
"    ). The bladder is advanced upward using an open, moistened gauze sponge (",
"    <a class=\"graphic graphic_figure graphicRef64997 \" href=\"mobipreview.htm?8/20/8513\">",
"     figure 5",
"    </a>",
"    ). Alternatively, sharp dissection can be performed using Metzenbaum scissors with the tips directed toward the uterus. At this point, the vesicovaginal peritoneal reflection is usually identified and can be entered sharply using scissors (",
"    <a class=\"graphic graphic_figure graphicRef51826 \" href=\"mobipreview.htm?15/18/15652\">",
"     figure 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef81305 \" href=\"mobipreview.htm?36/56/37763\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The anterior peritoneal fold is now usually visualized easily and the anterior cul-de-sac can be entered. The anterior peritoneal fold appears as a crescent-shaped line. The peritoneal reflection is grasped with smooth forceps, tented, and opened with scissors with the tips pointed toward the uterus. A Heaney or Deaver retractor is placed into this space to protect the bladder and to aid visualization of the abdominal contents. If the anterior cul-de-sac cannot be identified, a bent uterine sound can be placed through the posterior cul-de-sac to assist with visualization of the anterior peritoneal fold.",
"   </p>",
"   <p>",
"    If this reflection is not easily seen, there is no danger in delaying this step, as long as the operator has ascertained that the bladder has been advanced. To further protect the bladder, a Deaver or Heaney retractor is placed in the midline to keep the bladder out of the operative field. Blunt or sharp advancement of the bladder should precede each clamp placement until the vesicovaginal space is entered. If a bladder laceration occurs, the cystotomy may be repaired before or after completion of the hysterectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Ligating the uterine vessels",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardinal ligaments are identified, clamped, cut, and suture ligated in a manner similar to that used for the uterosacral ligaments. Continued traction on the cervix aids with the identification of these structures and with hemostasis (",
"    <a class=\"graphic graphic_figure graphicRef76778 \" href=\"mobipreview.htm?25/38/26211\">",
"     figure 8",
"    </a>",
"    ). The bladder is advanced out of the operative field using either a blunt or sharp dissection technique. Sharp dissection is generally preferred in those patients whose bladder is adherent to the lower uterine segment from previous surgery.",
"   </p>",
"   <p>",
"    Constant traction directed to the contralateral side from the operative site is maintained on the cervix. If the left uterine artery is to be ligated, as an example, the uterus is directed downward and to the right. This simple step aids visualization of the operative site.",
"   </p>",
"   <p>",
"    The uterine vessels are clamped in such a way as to incorporate the anterior and posterior leaves of the visceral peritoneum (",
"    <a class=\"graphic graphic_figure graphicRef55832 \" href=\"mobipreview.htm?16/44/17091\">",
"     figure 9",
"    </a>",
"    ). Although a double-clamp technique has been described, a single-clamp technique is adequate and decreases the potential risk of ureteral injury. In the patient with a large uterus, a second pedicle may be necessary to make certain that all branches of the uterine vasculature have been ligated (",
"    <a class=\"graphic graphic_figure graphicRef57316 \" href=\"mobipreview.htm?24/9/24723\">",
"     figure 10",
"    </a>",
"    ). Back bleeding is controlled with traction on the uterus.",
"   </p>",
"   <p>",
"    An alternative to suture ligation of vascular pedicles is use of electrosurgical methods. A meta-analysis of seven randomized trials including 662 women undergoing vaginal hysterectomy found that use of energy-based vessel sealing devices (eg, LigaSure&trade;, BiClamp&reg;) compared with suturing decreased blood loss by an average of 48 mL and operative duration by an average of 17 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/6\">",
"     6",
"    </a>",
"    ]. Use of this approach for vaginal hysterectomy requires a device that can achieve hemostasis in large vessels. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37737?source=see_link&amp;anchor=H27#H27\">",
"     \"Overview of electrosurgery\", section on 'Bipolar vessel sealing devices'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uterine morcellation may be required for the patient with an enlarged uterus; this can be started after ligation of the uterine vasculature and once entry into the anterior and posterior cul-de-sacs is achieved (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Uterine morcellation'",
"    </a>",
"    below). If morcellation is not necessary, the uterine fundus is delivered posteriorly (",
"    <a class=\"graphic graphic_figure graphicRef71757 \" href=\"mobipreview.htm?34/11/34994\">",
"     figure 11",
"    </a>",
"    ). This is accomplished by placing a tenaculum on the uterine fundus in successive bites. The surgeon's index finger is used to identify the utero-ovarian ligament and aid in clamp placement. The remainder of the utero-ovarian ligaments are clamped and cut (",
"    <a class=\"graphic graphic_figure graphicRef67218 \" href=\"mobipreview.htm?28/51/29491\">",
"     figure 12",
"    </a>",
"    ). A double-clamp technique has been described, but is not necessary. However, the pedicles are double-ligated first with a suture tie and followed by a suture ligature medial to the first tie (",
"    <a class=\"graphic graphic_figure graphicRef69506 \" href=\"mobipreview.htm?24/20/24899\">",
"     figure 13",
"    </a>",
"    ). A hemostat is placed on the second suture to aid in the identification of any bleeding and to assist with peritoneal closure if this is to be done. A hemostat is not placed on the first tie, as traction on a tied suture risks loosening the tie.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Salpingo-oophorectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the adnexa are to be removed, traction is placed on the ovary by grasping it with a Babcock clamp. A Heaney clamp is placed across the infundibulopelvic ligament and the ovary and tube are excised if the infundibulopelvic ligament is mobile and elongated. Both a suture tie and transfixion suture ligature are placed on this pedicle (",
"    <a class=\"graphic graphic_figure graphicRef74674 \" href=\"mobipreview.htm?2/45/2771\">",
"     figure 14",
"    </a>",
"    ). The fallopian tube can be taken as a separate pedicle if it is large. Most adnexa can be removed transvaginally in this manner; however, if the ovaries are not readily accessible, a pre-tied surgical loop can be used for ligation of this pedicle. When this technique is used, it is preferable to removal the round ligament as a separate pedicle, to reduce the size of the pedicle that is ligated using the surgical loop. Alternatively, oophorectomy may be accomplished via a laparoscope placed through the vagina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/7\">",
"     7",
"    </a>",
"    ] or abdominally. However, this is rarely necessary.",
"   </p>",
"   <p>",
"    A lap-strip is placed into the peritoneal cavity and each of the pedicles is visualized and inspected to ensure that hemostasis has been obtained. If any bleeding points are identified, a suture is used to ligate the bleeding vessel under direct vision. The pelvic peritoneum can be closed or left open (preferable); the peritoneum reforms in 24 to 48 hours when left open. If it is to be closed, the anterior peritoneal edge is identified and grasped using smooth tissue forceps. A continuous absorbable zero suture is begun at the 12-o'clock position and a pursestring suture is placed incorporating the distal portion of the left upper pedicle and the left uterosacral ligament. The posterior peritoneum is sutured as high as is practical; some surgeons believe that this helps to prevent the formation of an enterocele in the future. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35914?source=see_link\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\"",
"    </a>",
"    .) The right uterosacral ligament and the distal portion of the right upper pedicle are then incorporated, and this continuous suture ends at the point on the anterior peritoneum where it was begun. Before tying the peritoneal suture, the lap strip is removed and again the pedicles are checked for hemostasis. As the suture is tied, the surgeon must make certain that viscera have not prolapsed beyond the suture and are not ligated as the suture is secured (",
"    <a class=\"graphic graphic_figure graphicRef78007 \" href=\"mobipreview.htm?34/10/34979\">",
"     figure 15",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vaginal epithelium is reapproximated in either a vertical or horizontal manner using either a continuous suture or a series of interrupted sutures (",
"    <a class=\"graphic graphic_figure graphicRef66835 \" href=\"mobipreview.htm?21/12/21698\">",
"     figure 16",
"    </a>",
"    ). The sutures are placed through the entire thickness of the vaginal epithelium, making certain that the bladder is not entered. The peritoneum can be incorporated into these sutures, but this is not necessary. Whether the cuff is closed vertically or horizontally does not affect postoperative morbidity or vaginal depth. A small randomized clinical trial showed that there is increased vaginal depth with a vertical closure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A culdoplasty is recommended by some gynecologic surgeons to decrease the subsequent risk of enterocele formation and the potential for development of vaginal vault prolapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/9\">",
"     9",
"    </a>",
"    ]. A study which randomly assigned 100 consecutive women undergoing vaginal hysterectomy to a Moschcowitz type repair (closing the cul-de-sac and bringing the uterosacral-cardinal complex together in the midline), McCall culdoplasty (obliteration of the cul-de-sac with plication of the uterosacral-cardinal complex and elevation of any redundant posterior vaginal apex), or simple peritoneal closure found that the McCall procedure was significantly better for preventing enterocele after three years follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An absorbable suture is placed through the full thickness of the posterior vaginal wall at the apex of what will be the vaginal vault. The suture is then passed through the left uterosacral ligament pedicle, the posterior peritoneum, and the right uterosacral ligament and completed by passing the suture from the inside to the outside at the same point that it was begun. The suture is then tied, which approximates the uterosacral ligaments and posterior peritoneum.",
"   </p>",
"   <p>",
"    It is not necessary to use a vaginal pack or leave a bladder catheter in place.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ancillary procedures for complicated cases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal hysterectomy may be challenging in women with a large uterus or a lack of uterine descensus. A narrow pubic arch is also associated with an increased risk of failed vaginal hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Uterine morcellation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine morcellation refers to the piecemeal removal of a large, often myomatous uterus. It is not recommended in women with uterine cancer.",
"   </p>",
"   <p>",
"    Several methods have been described, including hemisection (bivalving),",
"    <span class=\"nowrap\">",
"     wedge/V-type",
"    </span>",
"    incision, or intramyometrial",
"    <span class=\"nowrap\">",
"     coring/Lash",
"    </span>",
"    procedure. The latter two techniques are most commonly used, generally in combination. The uterine vasculature must be ligated and the peritoneal cavity entered either posteriorly or anteriorly",
"    <strong>",
"     before",
"    </strong>",
"    beginning any type of morcellation.",
"   </p>",
"   <p>",
"    Intramyometrial coring is best suited for the diffusely enlarged uterine fundus. Coring generally begins with a circumferential incision into the lower uterine segment just above the cervix. The incision is continued circumferentially and cephalad in a slightly enlarging diameter. Constant traction should be maintained on the cervix as the uterus begins to elongate, to aid exposure of the incisional plane and to decrease blood loss. Care should be taken not to remove a small core of tissue, but to remove a significant volume of the central portion of the uterus. The overall result is an elongation of the uterus (",
"    <a class=\"graphic graphic_figure graphicRef56250 \" href=\"mobipreview.htm?24/14/24810\">",
"     figure 17",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Wedge morcellation is accomplished by removal of V-shaped tissue pieces, and is most commonly used for removal of anterior or posterior myomas or when a broad ligament myoma is encountered. Using a tenaculum, the posterior fundus is grasped and a V-type incision is made with a knife. A second tenaculum is attached to the piece of tissue that is to be removed and the incision is completed (",
"    <a class=\"graphic graphic_figure graphicRef55930 \" href=\"mobipreview.htm?21/50/22308\">",
"     figure 18",
"    </a>",
"    ). It is important not to extend the incision into the broad ligament or through the anterior portion of the uterine fundus. It is often possible to perform a myomectomy for removal of an intact myoma; this greatly reduces the overall size of the uterus.",
"   </p>",
"   <p>",
"    Uterine hemisection or bivalving is rarely performed. The uterus is split in the midline beginning at the cervix. One side of the uterus is then removed, followed by removal of the opposite side. If the uterus is still too large to remove after it has been bisected, the uterine half can be further morcellated (",
"    <a class=\"graphic graphic_figure graphicRef56759 graphicRef70385 graphicRef79676 \" href=\"mobipreview.htm?24/61/25562\">",
"     figure 19A-C",
"    </a>",
"    ). This method is most appropriate for a fundal, midline myoma.",
"   </p>",
"   <p>",
"    The only controlled trial evaluating these approaches randomly assigned 30 women scheduled for vaginal hysterectomy to",
"    <span class=\"nowrap\">",
"     bisection/morcellation",
"    </span>",
"    or coring to remove the uterus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/12\">",
"     12",
"    </a>",
"    ]. Over 70 percent of women in both groups had uteri weighing more than 280 g. The uterus was successfully extracted vaginally in all patients",
"    <span class=\"nowrap\">",
"     (14/14)",
"    </span>",
"    who underwent",
"    <span class=\"nowrap\">",
"     bisection/morcellation,",
"    </span>",
"    but four failures",
"    <span class=\"nowrap\">",
"     (4/16)",
"    </span>",
"    occurred with coring; surgery was completed in all of these patients after",
"    <span class=\"nowrap\">",
"     bisection/morcellation.",
"    </span>",
"    Operative time and blood loss was similar for both groups.",
"   </p>",
"   <p>",
"    The use of uterine morcellation to remove the enlarged uterus transvaginally is a safe and effective procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. Morbidity is less than that encountered at the time of abdominal hysterectomy. There also does not appear to be significant differences in the mean uterine weight, estimated blood loss, and complication rate in unsuccessful compared to successful vaginal hysterectomies. Therefore, uterine size alone is not an absolute contraindication to vaginal hysterectomy, and large uteri weighing more than 300 g are not necessarily related to a significant increase in failed vaginal hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A rare problem in excision of a myoma is loss of the specimen into the peritoneal cavity due to clamp slippage. Retrieval of the specimen can be difficult. After completing removal of the uterus, the patient's head can be elevated and lavage of the peritoneal cavity will bring the errant fibroid into the pelvis.",
"   </p>",
"   <p>",
"    Uterine volume may be reduced preoperatively by administration of a gonadotropin-releasing hormone agonist as a possible alternative to morcellation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/14/18666?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of treatment of uterine leiomyomas (fibroids)\", section on 'Medical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Poor uterine descensus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sometimes the degree of uterine mobility that was anticipated based upon office examination is not present at the examination under anesthesia or after the procedure is begun. The surgeon must decide whether to proceed with a vaginal approach or to stop and convert the procedure to an abdominal approach. If the problem relates to introital narrowing on access, a midline or mediolateral episiotomy can be performed or a Schuchardt type incision, in which the perineal and levator muscles are incised, can be used. If the problem stems from an enlarged uterus, morcellation can be begun after the uterine arteries have been ligated. However, lack of descent resulting from extensive adhesive disease usually requires an abdominal incision or packing the vagina and accessing the pelvis by means of laparoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Laparoscopic assistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopic assistance may be employed if visualization of the peritoneal cavity is needed; as an example, a difficult dissection of the adnexae is suspected, the peritoneum cannot be entered easily, a pedicle is lost and cannot be located vaginally, or if transvaginal palpation suggests abnormal anatomy. Laparotomy in these circumstances would also be feasible, but presumably more morbid.",
"   </p>",
"   <p>",
"    A variety of methods have been described to accomplish laparoscopic vaginal hysterectomy (LAVH), including endoscopic staples, electrosurgery, vibrational energy, and suture ligatures. No single method has proven superior.",
"   </p>",
"   <p>",
"    Following an examination under anesthesia, the perineum, vagina, and lower abdomen are prepped, a Foley catheter inserted, and standard laparoscopy drapes applied. A uterine manipulator is attached to the cervix through a side-opening Graves speculum, making certain to antevert the uterus.",
"   </p>",
"   <p>",
"    A Verres needle is inserted periumbilically, the abdomen insufflated, and the periumbilical trocar placed. Following confirmation of correct placement, either two trocars (5-mm, or 12-mm if endoscopic staples are used) are positioned in the right and left lower quadrants, 6 to 8 cm above the pubic rami and lateral to the inferior epigastric vessels (",
"    <a class=\"graphic graphic_figure graphicRef78970 \" href=\"mobipreview.htm?36/42/37540\">",
"     figure 20",
"    </a>",
"    ). The insertion of three 12-mm trocars allows for maximum flexibility of insertion and direction of the endoscopic stapling device. An intraabdominal survey should be performed after the trocars are in place, including an examination of the uterus, tubes, ovaries, and posterior cul-de-sac.",
"   </p>",
"   <p>",
"    The round ligaments are then desiccated or ligated, and incised. Beginning at the left round ligament, the peritoneum of the vesicouterine fold is incised with the hook scissors. Attachment of unipolar cautery to the scissors allows for dissection and desiccation of peritoneal vessels and maximizes visualization. The incision is continued across the lower uterine segment to the opposite round ligament (",
"    <a class=\"graphic graphic_figure graphicRef80513 \" href=\"mobipreview.htm?29/7/29813\">",
"     figure 21",
"    </a>",
"    ). Then the bladder is sharply dissected off the lower uterine segment and cervix. This is best accomplished by lifting the lower peritoneal edge with graspers, and using curved scissors to incise and dissect the loose areolar tissue and bladder from the uterus. To maintain good hemostasis, the electrocautery is activated prior to cutting. Some surgeons prefer to use a contact-tip neodymium:yttrium-aluminum-garnet laser for dissection, but this extremely expensive instrument has not been shown to be superior to cautery. The ureters are identified by incision of medial leaf of the broad ligament and dissection of the retroperitoneal space.",
"   </p>",
"   <p>",
"    If staples are to be used, the proper staple size is chosen and the stapling device is inserted through one of the lower abdominal ports on the same side of the uterus that is to be stapled. The infundibulopelvic ligament is ligated lateral to the ovary, if the ovaries are to be removed, and medial to the ovary if the ovaries are retained (",
"    <a class=\"graphic graphic_figure graphicRef63463 \" href=\"mobipreview.htm?35/49/36629\">",
"     figure 22",
"    </a>",
"    ). The tip of the stapler should be past the cut edge of the anterior peritoneum. Once positioned, the stapling unit is closed and locked into place. The closed position is inspected, paying particular attention that no bowel is enclosed and that the ureter is visualized and is free. The safety is released and the stapling unit is activated. After removing the stapling unit, the cut and stapled edges are inspected for hemostasis and proper staple alignment (",
"    <a class=\"graphic graphic_figure graphicRef77145 \" href=\"mobipreview.htm?41/33/42517\">",
"     figure 23",
"    </a>",
"    ). If satisfactory, the same procedure is performed on the opposite side. Some surgeons stop the laparoscopic portion of the procedure at this point, while others proceed with ligation or desiccation of the uterine vasculature.",
"   </p>",
"   <p>",
"    If electrosurgery is employed, the bipolar coagulation instrument is inserted and the areas described above are desiccated, rather than stapled.",
"   </p>",
"   <p>",
"    The uterine vasculature is desiccated and cut with the ureter and bladder under direct vision. If staple-ligation is used, the uterus is again pushed upward and to the side away from the area being stapled. The endoscopic staples are opened and aligned along the uterus, incorporating the uterine artery. The open stapling device is pushed down to the apex of the previously cut pedicle, the stapler is closed, and the position of the ureter is inspected (",
"    <a class=\"graphic graphic_figure graphicRef65691 \" href=\"mobipreview.htm?13/39/13942\">",
"     figure 24",
"    </a>",
"    ). If satisfactory, the stapler is fired and removed slowly, checking for hemostasis. The procedure is repeated on the opposite side. Some surgeons stop the laparoscopic portion of the procedure at this point, while others proceed with ligation of the cardinal ligaments with or without opening the anterior or posterior cul-de-sac.",
"   </p>",
"   <p>",
"    The cardinal ligaments can either be staple-ligated or desiccated with electrocautery. It is extremely important to visualize and avoid the ureter during this step. Once completed, the vagina can be entered through an anterior colpotomy incision. A posterior colpotomy incision can also be made, although it is not necessary and can be made much more easily through the vagina. Placing a sponge or manipulator into the vagina may facilitate making the colpotomy incision.",
"   </p>",
"   <p>",
"    The vaginal approach is begun when the endoscopic dissection is complete. The uterine manipulator is removed and a tenaculum is applied to the cervix. The vaginal hysterectomy is begun in standard fashion through a posterior cul-de-sac incision as described above. Following uterine removal and closure of the vagina, a pneumoperitoneum should be reestablished for inspection of the surgical pedicles, irrigation of the pelvis, and to confirm hemostasis. The trocars are removed and the skin incisions closed in standard fashion. Most patients are discharged on the afternoon of surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Doderlein procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another method for vaginal hysterectomy is the Doderlein vaginal hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/7,18,19\">",
"     7,18,19",
"    </a>",
"    ]. Using this method, an incision is made in the vaginal epithelium at the junction of the bladder and anterior cervix. The pubovesicocervical fascia is dissected from the lower uterine segment and the anterior cul-de-sac is entered. The cervix is pushed posteriorly and the uterine fundus is delivered through the anterior cul-de-sac. The hysterectomy is then begun much in the same manner that one would proceed with an abdominal procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE AND DISCHARGE INSTRUCTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of our postoperative regimens were formulated when patients were allowed to remain hospitalized for several days. Pressures to optimize hospital use have led to modification of these practices, which continue to evolve. As an example, it is not generally necessary to leave a bladder catheter in place postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. If a catheter is used, it should be removed no later than the morning following surgery.",
"   </p>",
"   <p>",
"    Intravenous fluids are generally administered for the first 24 hours to ensure that the patient remains well hydrated, especially if she experiences any nausea or vomiting. Early feeding of a regular diet can stimulate the bowel. While some surgeons begin with clear liquids and rapidly advance to a regular diet, others go straight to a regular diet, encouraging patients to select the foods they wish.",
"   </p>",
"   <p>",
"    Adequate control of postoperative pain is necessary. Patient-controlled analgesia can be utilized, either epidural or intravenous, or a opioid pain medication can be given as an intravenous or intramuscular injection. Oral analgesics are usually adequate on the first postoperative day.",
"   </p>",
"   <p>",
"    The woman is encouraged to resume her normal daily activities as quickly as is comfortable. Walking and stair climbing are encouraged; tub baths or showers are permissible. She should avoid lifting over approximately 20 lb of weight for four to six weeks after surgery to minimize stress on the healing fascia. Vaginal intercourse is also discouraged during this period to allow the vaginal cuff to heal completely. Driving should be avoided until full mobility returns and opioid analgesia is no longer required.",
"   </p>",
"   <p>",
"    The patient should call her surgeon if she experiences an increase in pain, persistent nausea or vomiting, bleeding heavier than a menstrual period, or any signs or symptoms of infection. She may return to work as soon as she has regained sufficient stamina and mobility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United Kingdom, the VALUE study, which included over 11,000 vaginal hysterectomies, reported crude rates for severe intraoperative and postoperative complications were 3.1 and 1.2 percent, respectively, for procedures performed in 1994-1995 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common complications are ureteral, bowel and bladder injuries, hemorrhage, and infection. The overall rate of unintended major surgical procedures accompanying or following vaginal hysterectomy is 3 to 5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Although uncommon, the severity of these complications warrants that they be clearly mentioned during preoperative counseling and the discussion documented.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Urologic issues",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Urinary incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysterectomy may result in damage to the nerve supply or supportive tissues of the pelvic floor which may lead to subsequent urinary incontinence; however, this controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In one large retrospective cohort study (n = 644,766), hysterectomy was associated with a twofold increase in risk of subsequent surgery for stress incontinence compared to women who had not undergone hysterectomy (hazard ratio 2.4, 95% CI 2.3-2.5). This difference was present regardless of the surgical approach used for the hysterectomy; women who had previous surgery for stress urinary incontinence or for whom the indication for hysterectomy was pelvic organ prolapse were excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/27\">",
"     27",
"    </a>",
"    ]. However, this study was limited by the absence of data on the prevalence of preexisting urinary incontinence symptoms. Some smaller studies have not found an association between hysterectomy and subsequent urinary incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Ureteral injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ureter can sometimes be visualized",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    palpated during vaginal hysterectomy. The best way to avoid ureteral injury is to place all clamps close to the uterus and keep the bladder out of the operative field, which displaces the ureters away from the operative field. If an injury is suspected, cystoscopic evaluation is especially helpful during vaginal hysterectomy, combined with intravenous administration of indigo carmen. Ureteral injuries occur in 0.2 per 1000 surgeries and the addition of pelvic floor reconstructive procedures does not appear to increase the risk of injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23,30,31\">",
"     23,30,31",
"    </a>",
"    ]. Urinary tract injury in gynecologic surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/46/14056?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7609?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Bladder injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder injuries occur in up to 2 percent of cases; concomitant pelvic floor repair does not appear to increase the risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23,30,31\">",
"     23,30,31",
"    </a>",
"    ]. The bladder is most commonly perforated during entry into the anterior cul-de-sac. A one- or two-layer running closure with a small caliber absorbable suture (eg, 3-0) is adequate, if the bladder has not been irradiated.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     Methylene blue",
"    </a>",
"    or sterile infant formula can be instilled into the bladder to confirm the adequacy of the repair, and the ureteral orifices observed cystoscopically to ensure they have not been compromised. The bladder should be drained until gross hematuria has cleared and for a minimum of three to four days, or until a cystogram confirms bladder healing. Urinary tract injury in gynecologic surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/46/14056?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7609?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Bowel injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel injuries are uncommon; the incidence is 0.4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Small bowel injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small bowel injury is rarely encountered during vaginal hysterectomy. Small defects of the serosal or muscular layers may be repaired vaginally using a single layer of continuous or interrupted 3-0 silk or synthetic absorbable suture material. Single layer closure of small bowel is adequate in most cases. If a large area has been injured, resection with reanastomosis may be necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/3/24631?source=see_link&amp;anchor=H6#H6\">",
"     \"Complications of gynecologic surgery\", section on 'Bowel injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Colonic injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ascending and descending colon and rectum can be injured during either abdominal or vaginal hysterectomy, the transverse colon is rarely damaged since it is well out of the operative field. Repair is similar to that described above for the small bowel. However, if the bowel has not been cleansed preoperatively and the injury is larger than 5.0 cm, a diverting colostomy may be rarely considered, especially if there is gross spillage of bowel contents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood loss averages 300 mL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/32\">",
"     32",
"    </a>",
"    ]. Significant arterial bleeding is usually from the uterine arteries or the ovarian vessels near the insertion of the infundibulopelvic ligaments and occurs in less than 1 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ]. Blindly clamping or mass ligature placement in bleeding areas should always be avoided, as one risks unnecessary ureteral or bowel injury. It is best to apply a pressure pack to tamponade the bleeding and then slowly remove the pack to visualize, isolate, and individually clamp the bleeding vessels. The use of surgical clips may be helpful. Venous bleeding is often more bothersome than arterial bleeding, but can usually be controlled with pressure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    suture ligation. Bleeding from peritoneal edges or denuded surfaces may be cauterized or topical hemostatic agents can be applied.",
"   </p>",
"   <p>",
"    If a vascular pedicle is lost during a vaginal hysterectomy and efforts at visualization from below are unsuccessful, blind clamping or suturing is ill advised. Laparoscopy can be used to identify and control the bleeding site, with laparotomy reserved for bleeding inaccessible to laparoscopic techniques or beyond the skill of the surgeon.",
"   </p>",
"   <p>",
"    Early and late postoperative hemorrhages occur in 2 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ]. Early postoperative hemorrhage after vaginal hysterectomy may present as bleeding from the vagina or as deteriorating vital signs, falling hematocrit level, and flank or abdominal pain. The first presentation usually represents bleeding from the vaginal cuff or one of the pedicles, while the latter presentation may represent retroperitoneal hemorrhage. These two situations are approached differently in evaluation and treatment, but both involve prompt stabilization of vital signs, fluid and blood product replacement, and constant surveillance of the patient's condition. The patient should be taken promptly to the examining room where the operative site is viewed and the vaginal cuff inspected. Bleeding from the vaginal cuff can usually be sutured in the examination room.",
"   </p>",
"   <p>",
"    Bleeding arising from above the cuff should be evaluated in the operating room. Physical examination typically reveals tenderness and dullness in the flank and abdominal distension. If the patient's condition stabilizes rapidly with intravenous fluids, she can be transfused and followed with serial hematocrits and vital signs. In many instances, the bleeding will tamponade and stop, forming a hematoma that will eventually reabsorb. The risk of this approach is that the hematoma will become infected, necessitating surgery if antibiotic therapy is not successful.",
"   </p>",
"   <p>",
"    Another option is to perform an abdominal exploration while the patient is stable and in good condition. This approach brings the added morbidity of a second anesthesia and an abdominal incision, but avoids the possibility of her condition deteriorating with continued delay or the possibility of a pelvic abscess later. General anesthesia should be administered and the vaginal operative site explored. Consideration may be given to laparoscopy, as this may allow identification and control of the bleeding site without the need for laparotomy. In some patients, radiographic ligation of the hypogastric vessels may be attempted to avoid surgery.",
"   </p>",
"   <p>",
"    Very infrequently, an otherwise stable patient will have a significant drop in hematocrit during the postoperative period, usually on days two to four. Ultrasound may demonstrate free intraperitoneal fluid. Ultimately, the patient may drain a large amount of watery brown fluid from the vagina. Antibiotics are not necessary.",
"   </p>",
"   <p>",
"    Management of general issues of bleeding in gynecologic surgery are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=see_link\">",
"     \"Management of hemorrhage in gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Febrile morbidity occurs in approximately 15 percent of women, one-half of whom have no obvious source [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ]. This rate can be reduced substantially with use of prophylactic antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/32\">",
"     32",
"    </a>",
"    ]. Infection after vaginal hysterectomy can be classified as vaginal cuff cellulitis, pelvic cellulitis, pelvic abscess, and infected pelvic hematoma; pelvic infection occurs in 4 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ]. Pelvic cellulitis is an infection of the soft tissues of the pelvis and usually begins about the third day after surgery. Although some degree of cuff cellulitis probably occurs after every hysterectomy, antibiotics are not required unless the fever persists.",
"   </p>",
"   <p>",
"    Regardless of the type of infection, treatment is initiated with broad-spectrum intravenous antibiotic therapy, which should be continued for 24 to 48 hours after the resolution of fever and symptoms. Oral antibiotics after parenteral therapy are not necessary. If the patient does not respond to parenteral antibiotic therapy or the pelvic examination findings are uncertain, an ultrasound may be helpful. In addition, the vaginal cuff should be opened using a Kelly clamp or uterine dressing forceps and allowed to drain.",
"   </p>",
"   <p>",
"    Most women will have an increase in cul-de-sac fluid following hysterectomy. The importance of these fluid collections is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Urinary retention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary retention is the only postoperative complication that is higher in patients undergoing vaginal hysterectomy compared to those undergoing abdominal hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ]. It usually results from pain or bladder atony. The bladder can be drained until the patient is able to void.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Fallopian tube prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolapse of the fallopian tube is an uncommon postoperative complication often confused with granulation tissue at the vaginal apex. Development of a hematoma or abscess at the vaginal apex is a predisposing factor. If the tissue at the top of the vaginal cuff does not respond to conservative treatment, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/53/42834?source=see_link\">",
"     silver nitrate",
"    </a>",
"    application or cryotherapy, a biopsy of the area is warranted to determine if it is tubal epithelium. Treatment is surgical; the surrounding vaginal epithelium is opened and widely undermined, and the tube is resected. Laparoscopic and vaginal approaches may be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Vaginal cuff evisceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evisceration of the small intestine into the vagina is a rare complication. It may be associated with the Valsalva maneuver or severe vomiting or coughing. Eviscerations usually occur in the early postoperative period, although in one series of 12 patients the mean time of occurrence was 27 months (range 5 to 48 months) after various pelvic surgeries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/33\">",
"     33",
"    </a>",
"    ]. Symptoms include abdominal-pelvic pain, vaginal bleeding or discharge, pressure in the vagina, and protrusion of bowel, which can become incarcerated.",
"   </p>",
"   <p>",
"    Acute management involves wrapping the bowel in moist saline soaked towels, administering intravenous fluids and broad spectrum antibiotics, and immediate laparotomy with inspection and replacement of the mesentery and small bowel. Any necrotic vaginal epithelium, or bowel, should be resected, and the vaginal cuff should be closed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Earlier menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who undergo hysterectomy may have an earlier menopause. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of hysterectomy\", section on 'Earlier menopause'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate for hysterectomy for a 40-year-old woman is approximately 5 per 10,000 cases, but increases to about 75 per 10,000 for a 50-year-old woman [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/34\">",
"     34",
"    </a>",
"    ]. If all women 15 to 44 years of age are included, the mortality rate is about 20 per 10,000 cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"     23",
"    </a>",
"    ].The mortality rate, standardized for age and race, is higher for hysterectomies associated with pregnancy or cancer than for procedures not associated with these conditions (29, 38, and 6 per 10,000 procedures, respectively); 61 percent of deaths occurred among women with these conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/35\">",
"     35",
"    </a>",
"    ]. Since almost all hysterectomies performed during pregnancy or for cancer are done abdominally, this contributes to the higher mortality rate of abdominal hysterectomy compared to the vaginal procedure (15 versus 4 per 10,000 procedures) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/35\">",
"     35",
"    </a>",
"    ]. The types of pelvic pathology (eg, severe endometriosis, tubo-ovarian abscess, large tumors) for which the abdominal route is undertaken also contribute to the higher mortality of this procedure.",
"   </p>",
"   <p>",
"    However, women undergoing hysterectomy avoid other long-term health risks, such as the development of cervical or endometrial cancer. It is estimated that women who undergo hysterectomy have an increased life expectancy of 14 to 73 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/36/35401/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;After hysterectomy, most women report relief of symptoms, improved quality of life, no adverse effect on sexual function, and satisfaction with their surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of hysterectomy\", section on 'Outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/41/3731?source=see_link\">",
"       \"Patient information: Hysterectomy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/16/6405?source=see_link\">",
"       \"Patient information: Abdominal hysterectomy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/48/34564?source=see_link\">",
"       \"Patient information: Vaginal hysterectomy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3109947\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hysterectomy (surgical removal of the uterus) may be performed via a vaginal or laparoscopically-assisted vaginal approach; other approaches include laparotomy and conventional or robot-assisted laparoscopy. The choice of surgical approach depends upon patient characteristics, patient preference, and the surgeon&rsquo;s expertise. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Entry into the peritoneal cavity for a vaginal hysterectomy is made through an incision at the cervico-vaginal junction. Choice of initial entry either posteriorly or anteriorly depends upon surgeon preference and the presence of adhesive disease. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Entry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Key steps in performing a vaginal hysterectomy include ligating the uterosacral and cardinal ligaments. The cardinal ligaments contain the uterine vessels. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Entry'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Ligating the uterine vessels'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ovaries and fallopian tubes may be removed or conserved during vaginal hysterectomy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Salpingo-oophorectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Closure for a vaginal hysterectomy is performed by reapproximating the vaginal epithelium in either a vertical or horizontal manner using either a continuous suture or a series of interrupted sutures (",
"      <a class=\"graphic graphic_figure graphicRef66835 \" href=\"mobipreview.htm?21/12/21698\">",
"       figure 16",
"      </a>",
"      ). The peritoneum can be incorporated into these sutures, but this is not necessary. A culdoplasty is recommended by some gynecologic surgeons to decrease the subsequent risk of enterocele formation and the potential for development of vaginal vault prolapse. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Closure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications of vaginal hysterectomy are ureteral, bowel and bladder injuries, hemorrhage, and infection. The overall rate of unintended major surgical procedures accompanying or following vaginal hysterectomy is 3 to 5 percent. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/1\">",
"      Larsson PG, Carlsson B. Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis? Infect Dis Obstet Gynecol 2002; 10:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/2\">",
"      ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2006; 108:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/3\">",
"      Kammerer-Doak DN, Rogers RG, Johnson Maybach J, Traynor Mickelson M. Vasopressin as an etiologic factor for infection in gynecologic surgery: a randomized double-blind placebo-controlled trial. Am J Obstet Gynecol 2001; 185:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/4\">",
"      Ascher-Walsh CJ, Capes T, Smith J, Michels A. Cervical vasopressin compared with no premedication and blood loss during vaginal hysterectomy: a randomized controlled trial. Obstet Gynecol 2009; 113:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/5\">",
"      Speer, P, Unger, JB. Does saline really decrease blood loss at vaginal hysterectomy as much as vasopressin. J Pelvic Surg 2001; 7:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/6\">",
"      Kroft J, Selk A. Energy-based vessel sealing in vaginal hysterectomy: a systematic review and meta-analysis. Obstet Gynecol 2011; 118:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/7\">",
"      Magos AL, Bournas N, Sinha R, et al. Transvaginal endoscopic oophorectomy. Am J Obstet Gynecol 1995; 172:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/8\">",
"      Vassallo BJ, Culpepper C, Segal JL, et al. A randomized trial comparing methods of vaginal cuff closure at vaginal hysterectomy and the effect on vaginal length. Am J Obstet Gynecol 2006; 195:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/9\">",
"      Chene G, Tardieu AS, Savary D, et al. Anatomical and functional results of McCall culdoplasty in the prevention of enteroceles and vaginal vault prolapse after vaginal hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/10\">",
"      Cruikshank SH, Kovac SR. Randomized comparison of three surgical methods used at the time of vaginal hysterectomy to prevent posterior enterocele. Am J Obstet Gynecol 1999; 180:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/11\">",
"      Harmanli OH, Khilnani R, Dandolu V, Chatwani AJ. Narrow pubic arch and increased risk of failure for vaginal hysterectomy. Obstet Gynecol 2004; 104:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/12\">",
"      Nazah I, Robin F, Jais JP, et al. Comparison between bisection/morcellation and myometrial coring for reducing large uteri during vaginal hysterectomy or laparoscopically assisted vaginal hysterectomy: results of a randomized prospective study. Acta Obstet Gynecol Scand 2003; 82:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/13\">",
"      Hoffman MS, DeCesare S, Kalter C. Abdominal hysterectomy versus transvaginal morcellation for the removal of enlarged uteri. Am J Obstet Gynecol 1994; 171:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/14\">",
"      Mazdisnian F, Kurzel RB, Coe S, et al. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure. Obstet Gynecol 1995; 86:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/15\">",
"      Benassi L, Rossi T, Kaihura CT, et al. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. Am J Obstet Gynecol 2002; 187:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/16\">",
"      Taylor SM, Romero AA, Kammerer-Doak DN, et al. Abdominal hysterectomy for the enlarged myomatous uterus compared with vaginal hysterectomy with morcellation. Am J Obstet Gynecol 2003; 189:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/17\">",
"      Stovall TG, Muneyyirci-Delale O, Summitt RL Jr, Scialli AR. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group. Obstet Gynecol 1995; 86:65.",
"     </a>",
"    </li>",
"    <li>",
"     Doderlein, A, Kronig, S. Die Technik Der Vaginalen Bauchhohlen-Operationen. Verlag Von S Hirzel, Leipzig, 1906.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/19\">",
"      Bohm JW, Lee FY. Vaginal hysterectomy be anterior delivery of the uterine corpus. South Med J 1976; 69:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/20\">",
"      Dunn TS, Shlay J, Forshner D. Are in-dwelling catheters necessary for 24 hours after hysterectomy? Am J Obstet Gynecol 2003; 189:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/21\">",
"      Alessandri F, Mistrangelo E, Lijoi D, et al. A prospective, randomized trial comparing immediate versus delayed catheter removal following hysterectomy. Acta Obstet Gynecol Scand 2006; 85:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/22\">",
"      McPherson K, Metcalfe MA, Herbert A, et al. Severe complications of hysterectomy: the VALUE study. BJOG 2004; 111:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/23\">",
"      Dicker RC, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. Am J Obstet Gynecol 1982; 144:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/24\">",
"      Harris WJ. Complications of hysterectomy. Clin Obstet Gynecol 1997; 40:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/25\">",
"      van der Vaart CH, van der Bom JG, de Leeuw JR, et al. The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms. BJOG 2002; 109:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/26\">",
"      Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet 2000; 356:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/27\">",
"      Altman D. Lancet 1007; 370:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/28\">",
"      de Tayrac R, Chevalier N, Chauveaud-Lambling A, et al. Is vaginal hysterectomy a risk factor for urinary incontinence at long-term follow-up? Eur J Obstet Gynecol Reprod Biol 2007; 130:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/29\">",
"      Thakar R, Ayers S, Clarkson P, et al. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 2002; 347:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/30\">",
"      Gilmour DT, Das S, Flowerdew G. Rates of urinary tract injury from gynecologic surgery and the role of intraoperative cystoscopy. Obstet Gynecol 2006; 107:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/31\">",
"      Ibeanu OA, Chesson RR, Echols KT, et al. Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol 2009; 113:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/32\">",
"      Meeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol 1997; 40:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/33\">",
"      Croak AJ, Gebhart JB, Klingele CJ, et al. Characteristics of patients with vaginal rupture and evisceration. Obstet Gynecol 2004; 103:572.",
"     </a>",
"    </li>",
"    <li>",
"     Bunker, JP, McPherson, K, Hennenman, PL. Elective hysterectomy. In Bunker JP, Baines BA, Mosteller F (Eds): Costs Risks and Benefits of Surgery. Oxford University Press, New York, 1977.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/35\">",
"      Wingo PA, Huezo CM, Rubin GL, et al. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985; 152:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/36/35401/abstract/36\">",
"      Cole P, Berlin J. Elective hysterectomy. Am J Obstet Gynecol 1977; 129:117.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3308 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35401=[""].join("\n");
var outline_f34_36_35401=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3109947\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS AND ALTERNATIVES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      OPERATIVE PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Initial steps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Entry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Ligating the uterine vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Salpingo-oophorectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ancillary procedures for complicated cases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Uterine morcellation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Poor uterine descensus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Laparoscopic assistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Doderlein procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      POSTOPERATIVE CARE AND DISCHARGE INSTRUCTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Urologic issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Ureteral injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Bladder injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Bowel injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Small bowel injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Colonic injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Urinary retention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Fallopian tube prolapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Vaginal cuff evisceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Earlier menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3109947\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3308\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3308|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/43/28339\" title=\"figure 1\">",
"      Incising posterior cul de sac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/30/28130\" title=\"figure 2\">",
"      Taking uterosacral ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/6/22626\" title=\"figure 3\">",
"      Transfixion uterosacral ligamnt",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/58/27555\" title=\"figure 4\">",
"      Cervicovaginal incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/20/8513\" title=\"figure 5\">",
"      Advancing bladder off cervix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/18/15652\" title=\"figure 6\">",
"      Anterior peritoneal reflection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/56/37763\" title=\"figure 7\">",
"      Entry into anterior culdesac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/38/26211\" title=\"figure 8\">",
"      Clamping cardinal ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/44/17091\" title=\"figure 9\">",
"      Clamping uterine vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/9/24723\" title=\"figure 10\">",
"      Clamping broad ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/11/34994\" title=\"figure 11\">",
"      Delivery of uterus vaginally",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/51/29491\" title=\"figure 12\">",
"      Clamping uteroovarian ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/20/24899\" title=\"figure 13\">",
"      Ligature uteroovarian pedicle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/45/2771\" title=\"figure 14\">",
"      Infundibulopelvic ligamnt sutur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/10/34979\" title=\"figure 15\">",
"      Peritoneal closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/12/21698\" title=\"figure 16\">",
"      Closure vaginal mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/14/24810\" title=\"figure 17\">",
"      Core uterine morcellation techn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/50/22308\" title=\"figure 18\">",
"      Morcellation by wedge resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/20/41284\" title=\"figure 19A\">",
"      Uterine morcellation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/36/13892\" title=\"figure 19B\">",
"      Uterine morcellation B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/37/11859\" title=\"figure 19C\">",
"      Uterine morcellation C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/42/37540\" title=\"figure 20\">",
"      Trocar placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/7/29813\" title=\"figure 21\">",
"      Creation of bladder flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/49/36629\" title=\"figure 22\">",
"      Adnexa at hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/33/42517\" title=\"figure 23\">",
"      Oophorectomy at lap vag hyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/39/13942\" title=\"figure 24\">",
"      Stapled uterine art ligation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3308|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/45/733\" title=\"table 1\">",
"      Antimicrobial prophylaxis for genitourinary surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=related_link\">",
"      Abdominal hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/3/24631?source=related_link\">",
"      Complications of gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/21/15706?source=related_link\">",
"      Elective oophorectomy or ovarian conservation at the time of hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/22/14698?source=related_link\">",
"      Laparoscopic approach to hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=related_link\">",
"      Management of hemorrhage in gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37737?source=related_link\">",
"      Overview of electrosurgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=related_link\">",
"      Overview of hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39800?source=related_link\">",
"      Overview of preoperative evaluation and preparation for gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/14/18666?source=related_link\">",
"      Overview of treatment of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/16/6405?source=related_link\">",
"      Patient information: Abdominal hysterectomy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/41/3731?source=related_link\">",
"      Patient information: Hysterectomy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/48/34564?source=related_link\">",
"      Patient information: Vaginal hysterectomy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=related_link\">",
"      Pelvic examination under anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35914?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/34/38440?source=related_link\">",
"      Surgical instruments for gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7609?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/46/14056?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_36_35402="Cardiac plane definition";
var content_f34_36_35402=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55080%7ECARD%2F64968%7ECARD%2F65139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55080%7ECARD%2F64968%7ECARD%2F65139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Cardiac plane definition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cardiac plane definition and display for tomographic imaging modalities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105:539. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular segmentation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 585px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Segmental analysis of LV walls based on schematic views, in a parasternal short-and long-axis orientation, at three different levels. The \"apex segments\" are usually visualized from apical 4-chamber, apical 2- and 3-chamber views. The apical cap can only be appreciated on some contrast studies. A 16-segment model can be used, without the apical cap, as described in an ASE 1989 document",
"    <sup>",
"     [1]",
"    </sup>",
"    . A 17-segment model, including the apical cap, has been suggested by the American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging",
"    <sup>",
"     [2]",
"    </sup>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2:358.",
"       </li>",
"       <li>",
"        Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation andnomenclature for tomographic imaging of the heart: a state-ment for healthcare professionals from the cardiac imagingcommittee of the council on clinical cardiology of the Amer-ican Heart Association. Circulation 2002; 105:539.",
"       </li>",
"      </ol>",
"      <br>",
"       Reproduced from: Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Coronary artery territories",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical distributions of the right coronary artery (RCA), the left anterior descending artery (LAD), and the circumflex artery (CX). The arterial distribution varies between patients. Some segments have variable coronary perfusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35402=[""].join("\n");
var outline_f34_36_35402=null;
var title_f34_36_35403="Rx protocol acute CVS";
var content_f34_36_35403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sample treatment protocol order sheet for a child having an acute attack of CVS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        In Emergency Department and in-hospital settings, an example of a regimen would include:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Darkened, quiet room, take vital signs every 4-6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If child is dehydrated, rehydrate with initial intravenous fluid bolus of 10 mL/kg normal 0.9% saline and repeat as clinically necessary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infuse 10% dextrose 0.45% (half normal) saline solution with potassium chloride as appropriate at 1.5 times maintenance rates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous ondansetron 0.3 mg/kg/dose every 6 hours x 24 hours (maximum 20 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous lorazepam 0.05 mg/kg/dose every 6 hours x 24 hours (maximum 2 mg per dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If child has moderate to severe abdominal pain, intravenous ketorolac 0.5 to 1 mg/kg/dose (maximum 30 mg per dose) every 6 hours x 24 hours (avoid in renal insufficiency or prior to hydration if dehydrated)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Admit child if &gt;5 percent dehydrated, no urine output &gt;12 hours, Na",
"        <sup>",
"         +",
"        </sup>",
"        &lt;130 mEq/L, anion gap &gt;18 mEq/L, or inability to stop emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allow oral fluid intake",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Li BU, Lefevre F, Chelimsky GG, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2008; 47:379. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35403=[""].join("\n");
var outline_f34_36_35403=null;
var title_f34_36_35404="Single agent chemo desmoids";
var content_f34_36_35404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F62085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F62085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Single-agent cytotoxic chemotherapy for desmoid tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients studied",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Response",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of response",
"       </td>",
"       <td class=\"subtitle1\">",
"        Author; year",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doxorubicin",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        <p>",
"         70 mg/m",
"         <sup>",
"          2",
"         </sup>",
"         every three weeks",
"        </p>",
"        <p>",
"         Dose reduced after two cycles to 50 mg/m",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"        <p>",
"         Cumulative dose: 450 mg/m",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        PR",
"       </td>",
"       <td>",
"        &gt;4 years after cessation of chemotherapy",
"       </td>",
"       <td>",
"        Seiter K; 1993",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Doxorubicin",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        3/6 PR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        de Camargo VP; 2010",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Epirubicin",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        30 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        every three weeks",
"       </td>",
"       <td>",
"        PR",
"       </td>",
"       <td>",
"        &gt;1 year",
"       </td>",
"       <td>",
"        Giaccone G; 1989",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Pegylated liposomal doxorubicin",
"       </td>",
"       <td>",
"        <p>",
"         1 adult",
"        </p>",
"        <p>",
"         3 children",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         20 to 50 mg/m",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"        <p>",
"         Cumulative dose: 160 to 430 mg/m",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         3 PR",
"        </p>",
"        <p>",
"         1 SD",
"        </p>",
"       </td>",
"       <td>",
"        9-40 months follow-up, no progression seen",
"       </td>",
"       <td>",
"        Wehl G; 2004",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Pegylated liposomal doxorubicin",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        8 PR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        de Camargo VP; 2010",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Pegylated liposomal doxorubicin",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        40 to 50 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        every four weeks, up to six cycles",
"       </td>",
"       <td>",
"        <p>",
"         4 PR",
"        </p>",
"        <p>",
"         <strong>",
"          10",
"         </strong>",
"         SD",
"        </p>",
"       </td>",
"       <td>",
"        <strong>",
"         9 to 45 months",
"        </strong>",
"       </td>",
"       <td>",
"        Constantinidou A; 2010",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PR: partial response, &ge;30 percent reduction in maximal dimension; NR: no response; SD: stable disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35404=[""].join("\n");
var outline_f34_36_35404=null;
var title_f34_36_35405="Temperature conversion";
var content_f34_36_35405=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fahrenheit and Celsius temperature equivalents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Fahrenheit",
"       </td>",
"       <td class=\"subtitle1\">",
"        Celsius",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fahrenheit",
"       </td>",
"       <td class=\"subtitle1\">",
"        Celsius",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        96.0",
"       </td>",
"       <td>",
"        35.6",
"       </td>",
"       <td>",
"        102.0",
"       </td>",
"       <td>",
"        38.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        96.2",
"       </td>",
"       <td>",
"        35.7",
"       </td>",
"       <td>",
"        102.2",
"       </td>",
"       <td>",
"        39.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        96.4",
"       </td>",
"       <td>",
"        35.8",
"       </td>",
"       <td>",
"        102.4",
"       </td>",
"       <td>",
"        39.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        96.6",
"       </td>",
"       <td>",
"        35.9",
"       </td>",
"       <td>",
"        102.6",
"       </td>",
"       <td>",
"        39.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        96.8",
"       </td>",
"       <td>",
"        36.0",
"       </td>",
"       <td>",
"        102.8",
"       </td>",
"       <td>",
"        39.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        97.0",
"       </td>",
"       <td>",
"        36.1",
"       </td>",
"       <td>",
"        103.0",
"       </td>",
"       <td>",
"        39.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        97.2",
"       </td>",
"       <td>",
"        36.2",
"       </td>",
"       <td>",
"        103.2",
"       </td>",
"       <td>",
"        39.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        97.4",
"       </td>",
"       <td>",
"        36.3",
"       </td>",
"       <td>",
"        103.4",
"       </td>",
"       <td>",
"        39.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        97.6",
"       </td>",
"       <td>",
"        36.4",
"       </td>",
"       <td>",
"        103.6",
"       </td>",
"       <td>",
"        39.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        97.8",
"       </td>",
"       <td>",
"        36.6",
"       </td>",
"       <td>",
"        103.8",
"       </td>",
"       <td>",
"        39.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        98.0",
"       </td>",
"       <td>",
"        36.7",
"       </td>",
"       <td>",
"        104.0",
"       </td>",
"       <td>",
"        40.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        98.2",
"       </td>",
"       <td>",
"        36.8",
"       </td>",
"       <td>",
"        104.2",
"       </td>",
"       <td>",
"        40.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        98.4",
"       </td>",
"       <td>",
"        36.9",
"       </td>",
"       <td>",
"        104.4",
"       </td>",
"       <td>",
"        40.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        98.6",
"       </td>",
"       <td>",
"        37.0",
"       </td>",
"       <td>",
"        104.6",
"       </td>",
"       <td>",
"        40.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        98.8",
"       </td>",
"       <td>",
"        37.1",
"       </td>",
"       <td>",
"        104.8",
"       </td>",
"       <td>",
"        40.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        99.0",
"       </td>",
"       <td>",
"        37.2",
"       </td>",
"       <td>",
"        105.0",
"       </td>",
"       <td>",
"        40.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        99.2",
"       </td>",
"       <td>",
"        37.3",
"       </td>",
"       <td>",
"        105.2",
"       </td>",
"       <td>",
"        40.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        99.4",
"       </td>",
"       <td>",
"        37.4",
"       </td>",
"       <td>",
"        105.4",
"       </td>",
"       <td>",
"        40.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        99.6",
"       </td>",
"       <td>",
"        37.6",
"       </td>",
"       <td>",
"        105.6",
"       </td>",
"       <td>",
"        40.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        99.8",
"       </td>",
"       <td>",
"        37.7",
"       </td>",
"       <td>",
"        105.8",
"       </td>",
"       <td>",
"        41.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100.0",
"       </td>",
"       <td>",
"        37.8",
"       </td>",
"       <td>",
"        106.0",
"       </td>",
"       <td>",
"        41.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100.2",
"       </td>",
"       <td>",
"        37.9",
"       </td>",
"       <td>",
"        106.2",
"       </td>",
"       <td>",
"        41.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100.4",
"       </td>",
"       <td>",
"        38.0",
"       </td>",
"       <td>",
"        106.4",
"       </td>",
"       <td>",
"        41.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100.6",
"       </td>",
"       <td>",
"        38.1",
"       </td>",
"       <td>",
"        106.6",
"       </td>",
"       <td>",
"        41.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100.8",
"       </td>",
"       <td>",
"        38.2",
"       </td>",
"       <td>",
"        106.8",
"       </td>",
"       <td>",
"        41.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        101.0",
"       </td>",
"       <td>",
"        38.3",
"       </td>",
"       <td>",
"        107.0",
"       </td>",
"       <td>",
"        41.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        101.2",
"       </td>",
"       <td>",
"        38.4",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        101.4",
"       </td>",
"       <td>",
"        38.6",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        101.6",
"       </td>",
"       <td>",
"        38.7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        101.8",
"       </td>",
"       <td>",
"        38.8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle4\" colspan=\"4\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        To convert from Fahrenheit to Celsius:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        (Temperature - 32) x (5/9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        To convert from Celsius to Fahrenheit:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        ((9/5) x Temperature) + 32",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35405=[""].join("\n");
var outline_f34_36_35405=null;
var title_f34_36_35406="Outcome MI and prior angina";
var content_f34_36_35406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    In-hospital mortality is lower in patients with angina prior to an acute MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 480px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among patients without a previous myocardial infarction (MI), the overall in-hospital mortality was lower in those with angina prior to the MI compared to those who did not have angina; this was primarily due to a lower incidence of cardiac rupture (top panel). Among patients with a prior MI, the in-hospital mortality was also lower in those with anginal episodes prior to the MI, primarily because of a lower incidence of cardiogenic shock or heart failure (HF) (bottom panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Kobayashi, Y, Miyazaki, S, Itoh, A, et al. Am J Cardiol 1998; 81:117.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35406=[""].join("\n");
var outline_f34_36_35406=null;
var title_f34_36_35407="Treatment algorithm for nociceptive pain";
var content_f34_36_35407=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Nociceptive pain: Pharmacologic approach",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 626px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Risk factors:",
"    </strong>",
"    <br>",
"     <ul>",
"      <li>",
"       Chronic kidney disease, advanced age - avoid NSAIDs and COX-2 inhibitors",
"      </li>",
"      <li>",
"       Peptic ulcer disease, glucocorticoid use - avoid NSAIDs",
"      </li>",
"      <li>",
"       Hepatic disease - avoid NSAIDs, COX-2 inhibitors, and acetaminophen (APAP); use TCAs or duloxetine first line",
"      </li>",
"      <li>",
"       Cardiovascular disease or risk - use lowest effective dose of NSAIDs; in patients who require treatment, suggest naproxen",
"      </li>",
"     </ul>",
"     <div class=\"footnotes\">",
"      NSAID: nonsteroidal anti-inflammatory drug; COX-2: cyclooxygenase 2 inhibitor; APAP: acetaminophen/paracetamol; TCA: tricyclic antidepressant; PPI: proton pump inhibitor.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_36_35407=[""].join("\n");
var outline_f34_36_35407=null;
